<SEC-DOCUMENT>0000950103-22-015976.txt : 20220919
<SEC-HEADER>0000950103-22-015976.hdr.sgml : 20220919
<ACCEPTANCE-DATETIME>20220919171245
ACCESSION NUMBER:		0000950103-22-015976
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20220919
DATE AS OF CHANGE:		20220919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CREDIT SUISSE AG
		CENTRAL INDEX KEY:			0001053092
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238458-02
		FILM NUMBER:		221251293

	BUSINESS ADDRESS:	
		STREET 1:		PARADEPLATZ 8
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8001
		BUSINESS PHONE:		01141 44 333 1111

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 1
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE / /FI
		DATE OF NAME CHANGE:	20050607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE FIRST BOSTON /                            /FI
		DATE OF NAME CHANGE:	19980115
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp180649_424b2-a435.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 63%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 37%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="image_001.jpg" ALT=""></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: #1F497D; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>FINANCIAL PRODUCTS</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt"><B>Pricing Supplement No. A435</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">To the Underlying Supplement dated
    June 18, 2020,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Product Supplement No. I-B dated June
    18, 2020,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Product Supplement No. I-C dated February
    4, 2022,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Prospectus Supplement dated June 18,
    2020 and</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Prospectus dated June 18, 2020</FONT></P></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed Pursuant
    to Rule 424(b)(2)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration Statement
    No. 333-238458-02</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.85pt; text-align: right"><FONT STYLE="font-size: 9pt">September
    15, 2022</FONT></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%">
    <P STYLE="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$742,000</P>
    <P STYLE="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Accelerated Return Equity Securities
    due September 20, 2027</FONT></P>
    <P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Linked to the Performance of the Lowest
    Performing of the Dow Jones Industrial Average<SUP>TM</SUP> and the Vanguard Value Index Fund</FONT></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Investors will not receive any interest or dividend payments. The securities do not guarantee any return of principal at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>If the Final Level of the Lowest Performing Underlying is equal to or greater than its Initial Level, investors will receive the principal
amount of their investment plus a return based on the leveraged upside performance of such Underlying. If the Final Level of the Lowest
Performing Underlying is less than its Initial Level, investors will lose 1% of their principal for each 1% decline in the level of the
Lowest Performing Underlying from its Initial Level to its Final Level. <B>You could lose your entire investment</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Senior unsecured obligations of Credit Suisse maturing September 20, 2027. Any payment on the securities is subject to our ability
to pay our obligations as they become due.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Minimum purchase of $1,000. Minimum denominations of $1,000 and integral multiples of $1,000 in excess thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The offering price for the securities was determined on September 15, 2022 (the &ldquo;Trade Date&rdquo;), and the securities are
expected to settle on September 20, 2022 (the &ldquo;Settlement Date&rdquo;). Delivery of the securities in book-entry form only will
be made through The Depository Trust Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The securities will not be listed on any exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves a number of risks. See &ldquo;Selected
Risk Considerations&rdquo; beginning on page 6 of this pricing supplement and &ldquo;Risk Factors&rdquo; beginning on page PS-3 of any
accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this pricing supplement or the
accompanying underlying supplement, any product supplement, the prospectus supplement and the prospectus. Any representation to the contrary
is a criminal offense.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 22%; border: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Price to Public</B><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 40%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Underwriting Discounts and Commissions</B><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Proceeds to Issuer</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Per security</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$1,000</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$7</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$993</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$742,000</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$5,194</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$736,806</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>(1)</SUP> Certain fiduciary accounts may pay a purchase price of
at least $993 per $1,000 principal amount of securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>(2)</SUP> We or one of our affiliates will pay discounts and commissions
of $7 per $1,000 principal amount of securities. CSSU or another broker or dealer will forgo some or all discounts and commissions with
respect to the sales of securities into certain fiduciary accounts. For more detailed information, please see &ldquo;Supplemental Plan
of Distribution (Conflicts of Interest)&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The agent for this offering, Credit Suisse Securities (USA) LLC (&ldquo;CSSU&rdquo;),
is our affiliate. For more information, see &ldquo;Supplemental Plan of Distribution (Conflicts of Interest)&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Credit Suisse currently estimates the value of each $1,000 principal
amount of the securities on the Trade Date is $992.80 (as determined by reference to our pricing models and the rate we are currently
paying to borrow funds through issuance of the securities (our &ldquo;internal funding rate&rdquo;)). See &ldquo;Selected Risk Considerations&rdquo;
in this pricing supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>The securities are not deposit liabilities and are not insured or
guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other
jurisdiction.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Credit Suisse</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">September 15, 2022</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Key Terms</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Issuer</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Credit Suisse AG (&ldquo;Credit Suisse&rdquo;), acting
through its London branch</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>Underlyings </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The securities are linked to the performance of the lowest
performing of the Underlyings set forth below. For more information on the Underlyings, see &ldquo;The Underlyings&rdquo; herein. Each
Underlying is identified in the table below, together with its Reuters ticker symbol and Initial Level:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 41%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 31%; border-bottom: Black 1pt solid; text-align: center"><B>Ticker</B></TD>
    <TD STYLE="width: 28%; border-bottom: Black 1pt solid; text-align: center"><B>Initial Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Dow Jones Industrial Average<SUP>TM</SUP></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">DJI &lt;Index&gt;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">30961.82</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Vanguard Value Index Fund</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">VTV UP &lt;Equity&gt;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$134.43</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Redemption Amount</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">At maturity, for each
$1,000 principal amount of securities, you will receive a Redemption Amount in cash that will equal $1,000 multiplied by the sum of one
plus the Security Performance Factor, calculated as set forth below. Any payment on the securities is subject to our ability to pay our
obligations as they become due.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Security Performance Factor</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Security Performance
Factor is expressed as a percentage and is calculated as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">If the Final Level of the
Lowest Performing Underlying is equal to or greater than its Initial Level, the Security Performance Factor will equal the product of
(i) the Upside Participation Rate multiplied by (ii) the Underlying Return of the Lowest Performing Underlying.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">If the Final Level of the
Lowest Performing Underlying is less than its Initial Level, the Security Performance Factor will equal the Underlying Return of the
Lowest Performing Underlying.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt">If the Final Level of the Lowest Performing Underlying
is less than its Initial Level, the Security Performance Factor will be negative and you will receive less than the principal amount of
your securities at maturity. You could lose your entire investment.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Lowest Performing Underlying</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Underlying with the
lowest Underlying Return.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Underlying Return</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For each Underlying, an amount calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center"><U>Final Level &ndash; Initial Level</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center">Initial Level</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>The Underlying Return for any Underlying will be negative
if its Final Level is less than its Initial Level.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Upside Participation Rate</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">171.50% </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Initial Level</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">For each Underlying,
the closing level of such Underlying on the Trade Date, as set forth in the table above.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Final Level</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">For each Underlying,
the closing level of such Underlying on the Valuation Date.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD STYLE="vertical-align: top; width: 33%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold">Trade Date</TD>
    <TD STYLE="vertical-align: top; width: 31%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">September 15, 2022</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 36%; border-top: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">Settlement Date</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">Expected to be September 20, 2022</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold">Valuation Date</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">September 15, 2027</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Subject to postponement as set forth in any accompanying product supplement under &ldquo;Description of the Securities&mdash;Postponement of calculation dates.&rdquo;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold">Maturity Date</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">September 20, 2027</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Subject to postponement as set forth in any accompanying product supplement under &ldquo;Description of the Securities&mdash;Postponement of calculation dates.&rdquo; If the Maturity Date is not a business day, the Redemption Amount will be payable on the first following business day, unless that business day falls in the next calendar month, in which case payment will be made on the first preceding business day.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Events of Default</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">With respect to these
securities, the first bullet of the first sentence of &ldquo;Description of Debt Securities&mdash;Events of Default&rdquo; in the accompanying
prospectus is amended to read in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">a default in payment of the
principal or any premium on any debt security of that series when due, and such default continues for 30 days;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CUSIP</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">22553QLM7 </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Additional Terms Specific to the Securities</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">You should read this pricing supplement together with the
underlying supplement dated June 18, 2020, the product supplements dated June 18, 2020 and February 4, 2022, the prospectus supplement
dated June 18, 2020 and the prospectus dated June 18, 2020, relating to our Medium-Term Notes of which these securities are a part. You
may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for
the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Underlying Supplement dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010320011950/dp130454_424b2-eus.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010320011950/dp130454_424b2-eus.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Product Supplement No. I-B dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010320011955/dp130588_424b2-ps1b.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010320011955/dp130588_424b2-ps1b.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Product Supplement No. I&ndash;C dated February 4, 2022:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010322002048/dp166585_424b2-ic.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010322002048/dp166585_424b2-ic.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Prospectus Supplement and Prospectus dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm">https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">In the event the terms of the securities described in this
pricing supplement differ from, or are inconsistent with, the terms described in the underlying supplement, any product supplement, the
prospectus supplement or prospectus, the terms described in this pricing supplement will control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Our Central Index Key, or CIK, on the SEC website is 1053092.
As used in this pricing supplement, &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo; refers to Credit Suisse.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">This pricing supplement, together with the documents listed
above, contains the terms of the securities and supersedes all other prior or contemporaneous oral statements as well as any other written
materials including preliminary or indicative pricing terms, fact sheets, correspondence, trade ideas, structures for implementation,
sample structures, brochures or other educational materials of ours. We may, without the consent of the registered holder of the securities
and the owner of any beneficial interest in the securities, amend the securities to conform to its terms as set forth in this pricing
supplement and the documents listed above, and the trustee is authorized to enter into any such amendment without any such consent. You
should carefully consider, among other things, the matters set forth in &ldquo;Selected Risk Considerations&rdquo; in this pricing supplement
and &ldquo;Risk Factors&rdquo; in any accompanying product supplement, &ldquo;Foreign Currency Risks&rdquo; in the accompanying prospectus,
and any risk factors we describe in the combined Annual Report on Form 20-F of Credit Suisse Group AG and us incorporated by reference
therein, and any additional risk factors we describe in future filings we make with the SEC under the Securities Exchange Act of 1934,
as amended, as the securities involve risks not associated with conventional debt securities. You should consult your investment, legal,
tax, accounting and other advisors before deciding to invest in the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Hypothetical Redemption Amounts at
Maturity</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The table and examples below make the following assumptions
and illustrate hypothetical Redemption Amounts payable at maturity on a $1,000 investment in the securities for a hypothetical range of
performance of the Lowest Performing Underlying. The actual Upside Participation Rate is set forth in &ldquo;Key Terms&rdquo; herein.
The hypothetical Redemption Amounts set forth below are for illustrative purposes only. The actual Redemption Amount applicable to a purchaser
of the securities will be based on the Final Level of the Lowest Performing Underlying. It is not possible to predict whether or by how
much the Final Level of the Lowest Performing Underlying will be less than its Initial Level. You should consider carefully whether the
securities are suitable to your investment goals. Any payment on the securities is subject to our ability to pay our obligations as they
become due. The numbers below have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid"><B>Principal Amount</B></TD>
    <TD STYLE="width: 58%; border-bottom: Black 1pt solid">$1,000 per security</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Upside Participation Rate</B></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">171.50% </FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="padding-top: 4pt; border-top: black 0.5pt solid; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 127.45pt">TABLE: Hypothetical Redemption Amounts</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 42%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Underlying Return of the Lowest Performing Underlying</TD>
    <TD STYLE="width: 24%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Security Performance Factor</TD>
    <TD STYLE="width: 34%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Redemption Amount per $1,000 Principal Amount of Securities</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">100%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">171.50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,715</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">154.35%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,543.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">80%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">137.20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,372</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">70%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">120.05%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,200.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">102.90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">85.75%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,857.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">40%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">68.60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,686</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">51.45%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,514.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">34.30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,343</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">10%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">17.15%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,171.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;10%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;10%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$900</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$800</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$700</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;40%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;40%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$500</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$400</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;70%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;70%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$300</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;80%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;80%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$200</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$100</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;100%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;100%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$0</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The following examples illustrate how the Redemption Amount
is calculated.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126pt"></TD><TD STYLE="width: 0.25in">1.</TD><TD>The Lowest Performing Underlying increases by 20% from its Initial Level to its Final Level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: center"><B>Final Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying A</TD>
    <TD STYLE="text-align: center">120% of Initial Level</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying B</TD>
    <TD STYLE="text-align: center">140% of Initial Level</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Because the Final Level of the Lowest Performing Underlying
is equal to or greater than its Initial Level, the Redemption Amount is determined as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD ROWSPAN="3" STYLE="vertical-align: top; width: 25%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Security Performance Factor</FONT></TD>
    <TD STYLE="width: 75%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= Upside Participation Rate &times; Underlying Return of the Lowest Performing Underlying</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= 171.50% &times; 20%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= 34.30%</FONT></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; (1 + Security Performance Factor)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; 1.343</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,343</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Because the Final Level of the Lowest Performing Underlying
is equal to or greater than its Initial Level, at maturity you would receive a Redemption Amount based on a leveraged return linked to
the appreciation in the level of the Lowest Performing Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126pt"></TD><TD STYLE="width: 0.25in">2.</TD><TD>The Lowest Performing Underlying decreases by 40% from its Initial Level to its Final Level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: center"><B>Final Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying A</TD>
    <TD STYLE="text-align: center">60% of Initial Level</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying B</TD>
    <TD STYLE="text-align: center">95% of Initial Level</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Because the Final Level of the Lowest Performing Underlying
is less than its Initial Level, the Redemption Amount is determined as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD ROWSPAN="2" STYLE="vertical-align: top; width: 25%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Security Performance Factor</FONT></TD>
    <TD STYLE="width: 75%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= Underlying Return of the Lowest Performing Underlying</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= &minus;40% </FONT></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; (1 + Security Performance Factor)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; 0.60</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $600</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Because the Final Level of the Lowest Performing Underlying
is less than its Initial Level, you will be exposed to any depreciation in the Lowest Performing Underlying from its Initial Level to
its Final Level.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Selected Risk Considerations</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">An investment in the
securities involves significant risks. This section describes material risks relating to an investment in the securities. These risks
are explained in more detail in the &ldquo;Risk Factors&rdquo; section of any accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Securities Generally</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>YOUR INVESTMENT IN THE SECURITIES MAY RESULT IN A LOSS
</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The securities do not guarantee any return of your principal
amount. You could lose up to $1,000 per $1,000 principal amount of securities. If the Final Level of the Lowest Performing Underlying
is less than its Initial Level, you will be fully exposed to any depreciation in the Lowest Performing Underlying and will lose 1% of
your principal for each 1% decline in the level of the Lowest Performing Underlying from its Initial Level to its Final Level. In this
case, the Redemption Amount you will receive will be less than the principal amount of the securities, and you will lose your entire investment
if the Final Level of the Lowest Performing Underlying falls to zero. It is not possible to predict whether or by how much the level of
the Lowest Performing Underlying will decrease from its Initial Level to its Final Level. Any payment on the securities is subject to
our ability to pay our obligations as they become due.<BR>
<BR>
</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE SECURITIES ARE SUBJECT TO THE CREDIT RISK OF CREDIT
SUISSE</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Investors are dependent on our ability to pay all amounts
due on the securities and, therefore, if we were to default on our obligations, you may not receive any amounts owed to you under the
securities. In addition, any decline in our credit ratings, any adverse changes in the market&rsquo;s view of our creditworthiness or
any increase in our credit spreads is likely to adversely affect the value of the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>REGARDLESS OF THE AMOUNT OF ANY PAYMENT YOU RECEIVE
ON THE SECURITIES, YOUR ACTUAL YIELD MAY BE DIFFERENT IN REAL VALUE TERMS</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Inflation may cause the real value of any payment you receive
on the securities to be less at maturity than it is at the time you invest. An investment in the securities also represents a forgone
opportunity to invest in an alternative asset that generates a higher real return. You should carefully consider whether an investment
that may result in a return that is lower than the return on alternative investments is appropriate for you.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE SECURITIES DO NOT PAY INTEREST</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We will not pay interest on the securities. You may receive
less at maturity than you could have earned on ordinary interest-bearing debt securities with similar maturities, including other of our
debt securities, since the Redemption Amount is based on the performance of the Lowest Performing Underlying. Because the Redemption Amount
may be less than the amount originally invested in the securities, the return on the securities (the effective yield to maturity) may
be negative. Even if it is positive, the return payable on each security may not be enough to compensate you for any loss in value due
to inflation and other factors relating to the value of money over time.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE PROBABILITY THAT THE FINAL LEVEL OF THE LOWEST PERFORMING
UNDERLYING WILL BE LESS THAN ITS INITIAL LEVEL WILL DEPEND ON THE VOLATILITY OF SUCH UNDERLYING</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&ldquo;Volatility&rdquo; refers to the frequency and magnitude
of changes in the level of an Underlying. The greater the expected volatility with respect to an Underlying on the Trade Date, the higher
the expectation as of the Trade Date that the Final Level of such Underlying could be less than its Initial Level, indicating a higher
expected risk of loss on the securities. The terms of the securities are set, in part, based on expectations about the volatility of the
Underlyings as of the Trade Date. The volatility of any Underlying can change significantly over the term of the securities. The level
of any Underlying could fall sharply, which could result in a significant loss of principal. You should be willing to accept the downside
market risk of the Underlyings and the potential to lose a significant amount of your principal at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE U.S. FEDERAL TAX CONSEQUENCES OF AN INVESTMENT IN
THE SECURITIES ARE UNCLEAR </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">There is no direct legal authority regarding the proper
U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).
Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the
treatment of the securities as prepaid financial contracts that are treated as &ldquo;open transactions.&rdquo; If the IRS were successful
in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the securities, including
the timing and character of income recognized by U.S. investors and the withholding tax consequences to non-U.S. investors, might be materially
and adversely affected. Even if the treatment of the securities described herein is respected, there is a substantial risk that a security
will be treated as a &ldquo;constructive ownership transaction,&rdquo; with potentially adverse consequences described below under &ldquo;United
States Federal Tax Considerations.&rdquo; Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the
U.S. federal tax treatment of the securities, possibly retroactively.<BR>
<BR>
</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Underlyings</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">YOU WILL BE SUBJECT TO RISKS RELATING TO THE RELATIONSHIP
BETWEEN THE UNDERLYINGS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities are linked
to the individual performance of each Underlying. As such, the securities will perform poorly if only one of the Underlyings performs
poorly. For example, if one Underlying appreciates from its Initial Level to its Final Level, but the Final Level of the Lowest Performing
Underlying is less than its Initial Level, you will be exposed to the depreciation of the Lowest Performing Underlying and you will not
benefit from the performance of any other Underlying. Each additional Underlying to which the securities are linked increases the risk
that the securities will perform poorly. By investing in the securities, you assume the risk that the Final Level of at least one of the
Underlyings will be less than its Initial Level, regardless of the performance of any other Underlying.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">It is impossible to predict
the relationship between the Underlyings. If the performances of the Underlyings exhibit no relationship to each other, it is more likely
that one of the Underlyings will cause the securities to perform poorly. However, if the performances of the equity securities included
in each Underlying are related such that the performances of the Underlyings are correlated, then there is less likelihood that only one
Underlying will cause the securities to perform poorly. Furthermore, to the extent that each Underlying represents a different market
segment or market sector, the risk of one Underlying performing poorly is greater. As a result, you are not only taking market risk on
each Underlying, you are also taking a risk relating to the relationship among the Underlyings.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THERE ARE RISKS ASSOCIATED WITH THE VANGUARD VALUE
INDEX FUND</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Although shares of the
Vanguard Value Index Fund (the &ldquo;Reference Fund&rdquo;) are listed for trading on a national securities exchange and a number of
exchange-traded funds generally have been traded on various national securities exchanges for varying periods of time, there is no assurance
that an active trading market will continue for the shares of the Reference Fund or that there will be liquidity in the trading market.
The Reference Fund is subject to management risk, which is the risk that the Reference Fund&rsquo;s investment strategy, the implementation
of which is subject to a number of constraints, may not produce the intended results. Pursuant to the Reference Fund&rsquo;s investment
strategy or otherwise, the investment advisor for the Reference Fund may add, delete or substitute the assets held by the Reference Fund.
Any of these actions could adversely affect the price of the shares of the Reference Fund and consequently the value of the securities.
For additional information about the Reference Fund, see &ldquo;The Underlyings&mdash;The Vanguard Value Index Fund &rdquo; herein.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE PERFORMANCE AND MARKET VALUE OF THE REFERENCE
FUND, PARTICULARLY DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE TO THE PERFORMANCE OF THE TRACKED INDEX</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Reference Fund will
generally invest in all of the equity securities included in the index tracked by the Reference Fund (the &ldquo;Tracked Index&rdquo;),
but may not fully replicate the Tracked Index. There may be instances where the Reference Fund&rsquo;s investment advisor may choose to
overweight a stock in the Tracked Index, purchase securities not included in the Tracked Index that the investment advisor believes are
appropriate to substitute for a security included in the Tracked Index or utilize various combinations of other available investment techniques.
In addition, the performance of the Reference Fund will reflect additional transaction costs and fees that are not included in the calculation
of the Tracked Index. Finally, </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">because the shares of
the Reference Fund are traded on a national securities exchange and are subject to market supply and investor demand, the market value
of one share of the Reference Fund may differ from the net asset value per share of the Reference Fund.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">During periods of market
volatility, securities held by the Reference Fund may be unavailable in the secondary market, market participants may be unable to calculate
accurately the net asset value per share of the Reference Fund and the liquidity of the Reference Fund may be adversely affected. This
kind of market volatility may also disrupt the ability of market participants to create and redeem shares in the Reference Fund. Further,
market volatility may adversely affect, sometimes materially, the prices at which market participants are willing to buy and sell shares
of the Reference Fund. As a result, under these circumstances, the market value of shares of the Reference Fund may vary substantially
from the net asset value per share of the Reference Fund. For these reasons, the performance of the Reference Fund may not correlate with
the performance of the Tracked Index. For additional information on the Reference Fund, see &ldquo;The Underlyings&mdash;The Vanguard
Value Index Fund&rdquo; herein.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE INVESTMENT STRATEGY REPRESENTED BY THE VANGUARD
VALUE INDEX FUND MAY NOT BE SUCCESSFUL</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Vanguard Value Index
Fund seeks to track the performance, before fees and expenses, of an index composed of large-capitalization U.S. equities that exhibit
value characteristics, which is currently the CRSP US Large Cap Value Index. The CRSP US Large Cap Value Index is designed to measure
the performance of companies included in the CRSP US Large Cap Index that are determined by the Center for Research in Security Prices
to exhibit relatively strong value characteristics (determined by reference to book-to-price ratio, forward earnings-to-price ratio, historic
earnings-to-price ratio, dividend-to-price ratio and sales-to-price ratio) and relatively weak growth characteristics (determined by reference
to future long-term growth in earnings per share (EPS), future short-term growth in EPS, 3-year historical growth in EPS, 3-year historical
growth in sales per share, current investment-to-assets ratio and return on assets). There is, however, no assurance that the Vanguard
Value Index Fund will outperform any other exchange-traded fund or any index or strategy that tracks U.S. stocks selected using other
criteria, and it may underperform its Tracked Index as a whole. A &ldquo;value&rdquo; investment strategy is premised on the goal of investing
in stocks that are determined to be relatively cheap or &ldquo;undervalued&rdquo; under the assumption that the value of those stocks
will increase over time as the market comes to reflect the &ldquo;fair&rdquo; market value of those stocks. However, the value characteristics
referenced by the CRSP US Large Cap Value Index may not be accurate predictors of undervalued stocks, and there is no guarantee that undervalued
stocks will appreciate. In addition, the CRSP US Large Cap Value Index&rsquo;s selection methodology includes a bias against stocks with
strong growth characteristics, and stocks with strong growth characteristics might outperform stocks with weak growth characteristics.
It is possible that the stock selection methodology of the CRSP US Large Cap Value Index will adversely affect its return and, consequently,
the price of shares of the Vanguard Value Index Fund and the value of your securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">NO OWNERSHIP RIGHTS RELATING TO THE UNDERLYINGS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Your return on the securities
will not reflect the return you would realize if you actually owned shares of the Reference Fund or the equity securities that comprise
the Underlyings. The return on your investment is not the same as the total return you would receive based on a purchase of shares of
the Reference Fund or the equity securities that comprise the Underlyings.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">NO VOTING RIGHTS OR DIVIDEND PAYMENTS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">As a holder of the securities,
you will not have voting rights or rights to receive cash dividends or other distributions or other rights with respect to shares of the
Reference Fund or the equity securities that comprise the Underlyings.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">ANTI-DILUTION PROTECTION IS LIMITED</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The calculation agent
will make anti-dilution adjustments for certain events affecting the Reference Fund. However, an adjustment will not be required in response
to all events that could affect the Reference Fund. If an event occurs that does not require the calculation agent to make an adjustment,
or if an adjustment is made but such adjustment does not fully reflect the economics of such event, the value of the securities may be
materially and adversely affected. See &ldquo;Description of the Securities&mdash;Adjustments&rdquo; in the relevant product supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">GOVERNMENT REGULATORY ACTION, INCLUDING LEGISLATIVE
ACTS AND EXECUTIVE ORDERS, COULD RESULT IN MATERIAL CHANGES TO THE UNDERLYINGS AND COULD NEGATIVELY AFFECT YOUR RETURN ON THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Government regulatory
action, including legislative acts and executive orders, could materially affect the Underlyings. For example, in response to recent executive
orders, stocks of companies that are determined to be linked to the People&rsquo;s Republic of China military, intelligence and security
apparatus may be delisted from a U.S. exchange, removed as a component in indices or exchange traded funds, or transactions in, or holdings
of, securities with exposure to such stocks may otherwise become prohibited under U.S. law. If government regulatory action results in
such consequences, there may be a material and negative effect on the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Issuer</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CREDIT SUISSE IS SUBJECT TO SWISS REGULATION</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">As a Swiss bank, Credit
Suisse is subject to regulation by governmental agencies, supervisory authorities and self-regulatory organizations in Switzerland. Such
regulation is increasingly more extensive and complex and subjects Credit Suisse to risks. For example, pursuant to Swiss banking laws,
the Swiss Financial Market Supervisory Authority (FINMA) may open resolution proceedings if there are justified concerns that Credit Suisse
is over-indebted, has serious liquidity problems or no longer fulfills capital adequacy requirements. FINMA has broad powers and discretion
in the case of resolution proceedings, which include the power to convert debt instruments and other liabilities of Credit Suisse into
equity and/or cancel such liabilities in whole or in part. If one or more of these measures were imposed, such measures may adversely
affect the terms and market value of the securities and/or the ability of Credit Suisse to make payments thereunder and you may not receive
any amounts owed to you under the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to Conflicts of Interest</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">HEDGING AND TRADING ACTIVITY</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We or any of our affiliates
may carry out hedging activities related to the securities, including in the Reference Fund or instruments related to the Underlyings.
We or our affiliates may also trade in the Reference Fund or instruments related to the Underlyings from time to time. Any of these hedging
or trading activities on or prior to the Trade Date and during the term of the securities could adversely affect our payment to you at
maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">POTENTIAL CONFLICTS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We and our affiliates
play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and as agent of the issuer
for the offering of the securities, hedging our obligations under the securities and determining their estimated value. In performing
these duties, the economic interests of us and our affiliates are potentially adverse to your interests as an investor in the securities.
Further, hedging activities may adversely affect any payment on or the value of the securities. Any profit in connection with such hedging
activities will be in addition to any other compensation that we and our affiliates receive for the sale of the securities, which creates
an additional incentive to sell the securities to you.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Estimated Value and Secondary
Market Prices of the Securities</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">UNPREDICTABLE ECONOMIC AND MARKET FACTORS WILL AFFECT
THE VALUE OF THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The payout on the securities
can be replicated using a combination of the components described in &ldquo;The estimated value of the securities on the Trade Date is
less than the Price to Public.&rdquo; Therefore, in addition to the levels of the Underlyings, the terms of the securities at issuance
and the value of the securities prior to maturity may be influenced by factors that impact the value of fixed income securities and options
in general, such as:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the expected and actual volatility of the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the expected and actual correlation, if any, between the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the dividend rate on the equity securities included in the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">investors&rsquo; expectations with respect to the rate of inflation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">geopolitical conditions and economic, financial, political, regulatory, judicial
or other events that affect the components included in the Underlyings or markets generally and which may affect the levels of the Underlyings;
and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">our creditworthiness, including actual or anticipated downgrades
in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">Some or all of these factors may influence the price that
you will receive if you choose to sell your securities prior to maturity. The impact of any of the factors set forth above may enhance
or offset some or all of any change resulting from another factor or factors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE ESTIMATED VALUE OF THE SECURITIES ON THE TRADE
DATE IS LESS THAN THE PRICE TO PUBLIC</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The initial estimated
value of your securities on the Trade Date (as determined by reference to our pricing models and our internal funding rate) is less than
the original Price to Public. The Price to Public of the securities includes any discounts or commissions as well as transaction costs
such as expenses incurred to create, document and market the securities and the cost of hedging our risks as issuer of the securities
through one or more of our affiliates (which includes a projected profit). These costs will be effectively borne by you as an investor
in the securities. These amounts will be retained by Credit Suisse or our affiliates in connection with our structuring and offering of
the securities (except to the extent discounts or commissions are reallowed to other broker-dealers or any costs are paid to third parties).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">On the Trade Date, we
value the components of the securities in accordance with our pricing models. These include a fixed income component valued using our
internal funding rate, and individual option components valued using proprietary pricing models dependent on inputs such as volatility,
correlation, dividend rates, interest rates and other factors, including assumptions about future market events and/or environments. These
inputs may be market-observable or may be based on assumptions made by us in our discretionary judgment. As such, the payout on the securities
can be replicated using a combination of these components and the value of these components, as determined by us using our pricing models,
will impact the terms of the securities at issuance. Our option valuation models are proprietary. Our pricing models take into account
factors such as interest rates, volatility and time to maturity of the securities, and they rely in part on certain assumptions about
future events, which may prove to be incorrect.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Because Credit Suisse&rsquo;s
pricing models may differ from other issuers&rsquo; valuation models, and because funding rates taken into account by other issuers may
vary materially from the rates used by Credit Suisse (even among issuers with similar creditworthiness), our estimated value at any time
may not be comparable to estimated values of similar securities of other issuers.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">EFFECT OF INTEREST RATE USED IN STRUCTURING THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The internal funding
rate we use in structuring notes such as these securities is typically lower than the interest rate that is reflected in the yield on
our conventional debt securities of similar maturity in the secondary market (our &ldquo;secondary market credit spreads&rdquo;). If on
the Trade Date our internal funding rate is lower than our secondary market credit spreads, we expect that the economic terms of the securities
will generally be less favorable to you than they would have been if our secondary market credit spread had been used in structuring the
securities. We will also use our internal funding rate to determine the price of the securities if we post a bid to repurchase your securities
in secondary market transactions. See &ldquo;&mdash;Secondary Market Prices&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">SECONDARY MARKET PRICES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">If Credit Suisse (or
an affiliate) bids for your securities in secondary market transactions, which we are not obligated to do, the secondary market price
(and the value used for account statements or otherwise) may be higher or lower than the Price to Public and the estimated value of the
securities on the Trade Date. The estimated value of the securities on the cover of this pricing supplement does not represent a minimum
price at which we would be willing to buy the securities in the secondary market (if any exists) at any time. The secondary market price
of your securities at any time cannot be predicted and will reflect the then-current estimated value determined by reference to our pricing
models, the related inputs and other factors, including our internal funding rate, customary bid and ask spreads and other transaction
costs, changes in market conditions and deterioration or improvement in our creditworthiness. In circumstances where our internal funding
rate is higher than our secondary market credit spreads, our </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">secondary market bid
for your securities could be less favorable than what other dealers might bid because, assuming all else equal, we use the higher internal
funding rate to price the securities and other dealers might use the lower secondary market credit spread to price them. Furthermore,
assuming no change in market conditions from the Trade Date, the secondary market price of your securities will be lower than the Price
to Public because it will not include any discounts or commissions and hedging and other transaction costs. If you sell your securities
to a dealer in a secondary market transaction, the dealer may impose an additional discount or commission, and as a result the price you
receive on your securities may be lower than the price at which we may repurchase the securities from such dealer.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We (or an affiliate)
may initially post a bid to repurchase the securities from you at a price that will exceed the then-current estimated value of the securities.
That higher price reflects our projected profit and costs, which may include discounts and commissions that were included in the Price
to Public, and that higher price may also be initially used for account statements or otherwise. We (or our affiliate) may offer to pay
this higher price, for your benefit, but the amount of any excess over the then-current estimated value will be temporary and is expected
to decline over a period of approximately three months. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities are not
designed to be short-term trading instruments and any sale prior to maturity could result in a substantial loss to you. You should be
willing and able to hold your securities to maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">LACK OF LIQUIDITY</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities will not
be listed on any securities exchange. Credit Suisse (or its affiliates) intends to offer to purchase the securities in the secondary market
but is not required to do so. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the
securities when you wish to do so. Because other dealers are not likely to make a secondary market for the securities, the price at which
you may be able to trade your securities is likely to depend on the price, if any, at which Credit Suisse (or its affiliates) is willing
to buy the securities. If you have to sell your securities prior to maturity, you may not be able to do so or you may have to sell them
at a substantial loss.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Supplemental Use of Proceeds and Hedging</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We intend to use the proceeds of this offering for our
general corporate purposes, which may include the refinancing of existing debt outside Switzerland. Some or all of the proceeds we receive
from the sale of the securities may be used in connection with hedging our obligations under the securities through one or more of our
affiliates. Such hedging or trading activities on or prior to the Trade Date and during the term of the securities (including on any calculation
date, as defined in any accompanying product supplement) could adversely affect the value of the Underlyings and, as a result, could decrease
the amount you may receive on the securities at maturity. For additional information, see &ldquo;Supplemental Use of Proceeds and Hedging&rdquo;
in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The Underlyings</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>The Dow Jones Industrial Average<SUP>TM</SUP></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For more information on the Dow Jones Industrial Average<SUP>TM</SUP>,
see &ldquo;The Reference Indices&mdash;The S&amp;P Dow Jones Indices&mdash;The Dow Jones Industrial Average<SUP>TM</SUP>&rdquo; in the
accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>The Vanguard Value Index Fund</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We have derived all information contained herein regarding
the Vanguard Value Index Fund from publicly available information. Such information reflects the policies of, and is subject to change
by, the Vanguard Group, Inc., which maintains and manages the Vanguard Value Index Fund and acts as investment advisor to the Vanguard
Value Index Fund. We have not conducted any independent review or due diligence of any publicly available information with respect to
the Vanguard Value Index Fund.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The Vanguard Value Index Fund is an exchange-traded fund
that seeks to track the performance, before fees and expenses, of the CRSP US Large Cap Value Index, a broadly diversified index predominantly
made up of value stocks of large U.S. companies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The Vanguard Index Funds is a registered investment company
that consists of numerous separate investment portfolios, including the Vanguard Value Index Fund. Information filed by the Vanguard Index
Funds with the SEC under the Securities Act and the Investment Company Act can be found by reference to its SEC file numbers: 002-56846
and 811-02652. Shares of the Vanguard Value Index Fund are listed on the NYSE Arca under ticker symbol &ldquo;VTV.&rdquo; Information
from outside sources is not incorporated by reference in, and should not be considered part of, this pricing supplement or the accompanying
product supplement, the prospectus supplement and the prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Historical Information</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The following graphs set forth the historical performance
of the Underlyings based on the closing levels of such Underlyings from January 3, 2017 through September 15, 2022. We obtained the historical
information below from Bloomberg, without independent verification. The closing levels reported by Bloomberg may not be the same as the
closing levels derived from the applicable Reuters page.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">You should not take the historical levels of the Underlyings
as an indication of future performance of the Underlyings or the securities. Any historical trend in the levels of the Underlyings during
any period set forth below is not an indication that the levels of the Underlyings are more or less likely to increase or decrease at
any time over the term of the securities. The graphs below may have been adjusted to reflect certain corporate actions such as stock splits
and reverse stock splits.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For additional information on the Underlyings, see &ldquo;The
Underlyings&rdquo; herein.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">The closing level of the Dow Jones Industrial Average<SUP>TM</SUP>
on September 15, 2022 was 30961.82.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.gif" ALT="" STYLE="height: 354px; width: 551px"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border-top: Black 1pt solid; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">The closing level of the Vanguard Value Index Fund on September
15, 2022 was $134.43.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">United States Federal Tax Considerations</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">This discussion supplements and, to the extent inconsistent
therewith, supersedes the discussion in the accompanying product supplement under &ldquo;United States Federal Tax Considerations.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">There are no statutory, judicial or administrative authorities
that address the U.S. federal income tax treatment of the securities or instruments that are similar to the securities. In the opinion
of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, a security should be treated as a prepaid
financial contract that is an &ldquo;open transaction&rdquo; for U.S. federal income tax purposes. However, there is uncertainty regarding
this treatment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Assuming this treatment of the securities is respected
and subject to the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following
U.S. federal income tax consequences should result:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or other
disposition.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or other disposition (including retirement) of a security, you should recognize gain or loss equal to the difference between
the amount realized and your tax basis in the security. Subject to the discussion below concerning the potential application of the &ldquo;constructive
ownership&rdquo; rules under Section 1260 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), such gain or loss
should be long-term capital gain or loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Even if the treatment of the securities as described herein
is respected, there is a substantial risk that your purchase of a security will be treated as entry into a &ldquo;constructive ownership
transaction,&rdquo; within the meaning of Section 1260 of the Code. In that case, all or a portion of any long-term capital gain you would
otherwise recognize in respect of your securities would be recharacterized as ordinary income to the extent such gain exceeded the &ldquo;net
underlying long-term capital gain.&rdquo; Any long-term capital gain recharacterized as ordinary income under Section 1260 would be treated
as accruing at a constant rate over the period you held your securities, and you would be subject to an interest charge in respect of
the deemed tax liability on the income treated as accruing in prior tax years. Due to the lack of governing authority under Section 1260,
our counsel is not able to opine as to whether or how Section 1260 applies to the securities. You should read the section entitled &ldquo;United
States Federal Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Securities Treated as Prepaid Financial Contracts that
are Open Transactions&mdash;Possible Application of Section 1260 of the Code&rdquo; in the accompanying product supplement for additional
information and consult your tax advisor regarding the potential application of the &ldquo;constructive ownership&rdquo; rule.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We do not plan to request a ruling from the IRS regarding
the treatment of the securities, and the IRS or a court might not agree with the treatment described herein. In particular, the IRS could
treat the securities as contingent payment debt instruments, in which case the tax consequences of ownership and disposition of the securities,
including the timing and character of income recognized, could be materially and adversely affected. Moreover, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
In addition, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>Non-U.S. Holders </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Subject to the discussions in the next paragraph and in
&ldquo;United States Federal Tax Considerations<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&mdash;</FONT>Tax Consequences
to Non-U.S. Holders&rdquo; and &ldquo;United States Federal Tax Considerations<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&mdash;</FONT>FATCA&rdquo;
in the</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">accompanying product supplement, if you are a Non-U.S.
Holder (as defined in the accompanying product supplement) of the securities, you generally should not be subject to U.S. federal withholding
or income tax in respect of any amount paid to you with respect to the securities, provided that (i) income in respect of the securities
is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification
requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">As discussed under &ldquo;United States Federal Tax Considerations<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&mdash;</FONT>Tax
Consequences to Non-U.S. Holders<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&mdash;</FONT>Dividend Equivalents under Section
871(m) of the Code&rdquo; in the accompanying product supplement, Section 871(m) of the Internal Revenue Code generally imposes a 30%
withholding tax on &ldquo;dividend equivalents&rdquo; paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments
linked to U.S. equities or indices that include U.S. equities. Treasury regulations under Section 871(m), as modified by an IRS notice,
exclude from their scope financial instruments issued prior to January 1, 2025 that do not have a &ldquo;delta&rdquo; of one with respect
to any U.S. equity. Based on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities
should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any
U.S. equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">A determination that the securities are not subject to
Section 871(m) is not binding on the IRS, and the IRS may disagree with this determination. Moreover, Section 871(m) is complex and its
application may depend on your particular circumstances, including your other transactions. You should consult your tax advisor regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">If withholding tax applies to the securities, we will not
be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>You should read the section entitled &ldquo;United States
Federal Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>You should also consult your tax advisor regarding all
aspects of the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Supplemental Plan of Distribution (Conflicts of Interest)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Under the terms and subject to the conditions contained
in a distribution agreement dated May 7, 2007, as amended, which we refer to as the distribution agreement, we have agreed to sell the
securities to CSSU.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The distribution agreement provides that CSSU is obligated
to purchase all of the securities if any are purchased.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CSSU will offer the securities at the offering price set
forth on the cover page of this pricing supplement and will receive discounts and commissions of $7 per $1,000 principal amount of securities.
CSSU may re-allow some or all of the discount on the principal amount per security on sales of such securities by other brokers or dealers.
CSSU or another broker or dealer will forgo some or all discounts and commissions with respect to the sales of securities into certain
fiduciary accounts. If all of the securities are not sold at the initial offering price, CSSU may change the public offering price and
other selling terms.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">An affiliate of Credit Suisse has paid or may pay in the
future a fixed amount to broker-dealers in connection with the costs of implementing systems to support these securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We expect to deliver the securities against payment for
the securities on the Settlement Date indicated herein, which may be a date that is greater than two business days following the Trade
Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle
in two business days, unless the parties to a trade expressly agree otherwise. Accordingly, if the Settlement Date is more than two business
days after the Trade Date, purchasers who wish to transact in the securities more than two business days prior to the Settlement Date
will be required to specify alternative settlement arrangements to prevent a failed settlement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The agent for this offering, CSSU, is our affiliate. In
accordance with FINRA Rule 5121, CSSU may not make sales in this offering to any of its discretionary accounts without the prior written
approval of the customer. A portion of the net proceeds from the sale of the securities will be used by CSSU or one of its affiliates
in connection with hedging our obligations under the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For further information, please refer to &ldquo;Underwriting
(Conflicts of Interest)&rdquo; in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Validity of the Securities</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="background-color: white">In the opinion of
Davis Polk &amp; Wardwell LLP, as United States counsel to Credit Suisse, when the securities offered by this pricing supplement have
been executed and issued by Credit Suisse and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities will be valid and binding obligations of Credit Suisse, enforceable against Credit Suisse in accordance with their terms,
subject to (i) applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, (ii) concepts of reasonableness
and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of
bad faith) and (iii) possible judicial or regulatory actions or application giving effect to governmental actions or foreign laws affecting
creditors&rsquo; rights, provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer
or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date of this pricing supplement
and is limited to the laws of the State of New York, except that such counsel expresses no opinion as to the application of state securities
or Blue Sky laws to the securities. Insofar as this opinion involves matters governed by Swiss law, Davis Polk &amp; Wardwell LLP has
relied, without independent inquiry or investigation, on the opinion of Homburger AG, dated August 12, 2022 and filed by Credit Suisse
as an exhibit to a Current Report on Form 6-K on August 12, 2022. The opinion of Davis Polk &amp; Wardwell LLP is subject to the same
assumptions, qualifications and limitations with respect to such matters as are contained in the opinion of Homburger AG. In addition,
the opinion of Davis Polk &amp; Wardwell LLP is subject to customary assumptions about the establishment of the terms of the securities,
the trustee&rsquo;s authorization, execution and delivery of the indenture and its authentication of the securities, and the validity,
binding nature and enforceability of the indenture with respect to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell
LLP dated August 12, 2022, which was filed by Credit Suisse as an exhibit to a Current Report on Form 6-K on August 12, 2022. Davis Polk
&amp; Wardwell LLP expresses no opinion as to waivers of objections to venue, the subject matter or personal jurisdiction of a United
States federal court or the effectiveness of service of process other than in accordance with applicable law. In addition, such counsel
notes that the enforceability in the United States of Section 10.08(c) of the indenture is subject to the limitations set forth in the
United States Foreign Sovereign Immunities Act of 1976.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5.5in; text-align: right">Accelerated Return Equity Securities&nbsp;&nbsp;&#9;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><IMG SRC="image_001.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>CREDIT SUISSE SECURITIES (USA) LLC</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">credit-suisse.com</P>
    <P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Copyright &copy; 2022 Credit Suisse Group AG and/or its affiliates. All rights reserved.&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp180649_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Exhibit
107.1</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">The pricing supplement
to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price of that offering
is $742,000.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X .D# 2(  A$! Q$!_\0
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M@C\1TS5.$DKM$J2>B-BBBBI*"BBB@ HHHH **** /$OC=X=$-W:>(($P)_\
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M8Z9L^P?9U^S[.FS;Q^E:5$DK^9,'J><> '\3>,= GU"?Q9>6TD=RT 5((F&
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MQMDD(5?:0OH#D''M]:J24TY1^9,6XM19K?##7=5UF;7HM3OI+H6ERL<1=5!
M^;T ]!6WXAU"\L_%7ABWM[EXX+N>:.>, 8D CR,\9X([5RGP?XO_ !6IZB]7
M(_%ZZ+Q4?^*R\'#O]JG_ /11HDE[1K^M@BWR+^NIGZYK>J6?Q=T/28;V1=/N
M[??+;[5P3^\[XS_".]7?&/B*^M-=T7P[IEU'97&I.=]Y(@;RD'90>"Q.0,^W
MK6'XE_Y+GX8_Z]#_ .U:Z?QEX,T[QG:I!/,8+VV&Z&>/EDW>J]U.WVZ<'K1[
MJ<;]@U?-;N+I^G>(]+UV 3ZR^J:7,C"03PHLD+@94@J!D'I_^NLB\UK5=?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=A)P)B 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+5BP# P<&'C"
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M\(R&(QQ0#G'!-D;%74D45R ^F$W06)T,<);6:@@H0"T SPI0*G2*.G!I;!(
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M36S:LJMUV"UDHTH- _?UO1%ICV8,<*"D'# TRR6!9X\!@,#:H@[L$" Q;6E
M//^6-"K\K'!G_DNBO!)S/1%Q*UF+F<"A( $)(/1#(+NB FD00 7&.:8O,SH6
MSV8&H=,8*0QMB0T5?G :;G%F-WB24T&(4R,4)@8<<;PA +9AI:(![EHB*]AE
MPL#! IVF I#@C+GXQSXJ_ X!9@25FQA@QI\AB8^.Z>+3QM8^)7K20_: @&<P
M99U0#H _ 9" * ="@'Y(P#H*<*5=WM2;_8@K ,7K1P0"(*K92 "7_0@ Q?@!
M 7J@!P*$,0@#(""!*8ELE=Z!@#,!H YR0$ S#[@F?R"PF'Q  '#9]%0 (H"
M=TC31>?4#@3603$7I1*7 U' /B+ CL\9I)K:%,@ (,#_J$_Z\Y\ #:A !TK0
M@AKTH A-J$(7RM"&.O2A$(VH0+<!+X=LYP#IF,<[0+(=6Y)D._9T2#H.T$Z.
M4'0A!S"F02Y:$X0A3 'Y.( M92K1B-(T;51H#T2>@28?^<,CSS.)YAJRJ0-2
M9#L'48#,*IJ?G_VN("BZ'DPN$YH1$$R,Q.%631O:CW?MD3,A?8B5J,@9*OP)
M(Z AQTED:%%6260"/TAF04;@580@K6WLNY=,U ,:M,Q(,G#3ZE85BB/;W:]H
M'FT(3X4#)0>$BR-!+<E0&?(.SIRU(6Z5R(P$*Q -)4%L,^%B6KB8-QQ4(0*<
M':Q!#\ B(*RC&P)[0!6H8%7&_U0A;M,4'Y'<HKX=&2"1M?TA)-+"6DBT10&(
MK"AH'BL8X!+F'54(TVQK.YO;5F%*PTHD%0+P5-[69@*08,>6M%@\"=2('Z<Y
M)0@@ 1@(2$D[ 3 4)*R3G'BH: 1KTF(^1E"!R@3 2%68Y66V!U4'X - ]:&D
M[A15 8"E P2'NA%D3ANR T0@#/$ @6?&&X#U0BY)A]K30!  A+[((QX-H&L$
MNFH_U1ZT730297 @ 0X 46&CC?E! &RUN96I!0@.4*^I_JNOV#"J'Y@QUW,.
M$M3$@* ?DP+ /&2F8]9AM3@!^$'-L/<- T2&B# CCJFZFJ9G)"L)X%@-%=+B
M5B:*:_\T!EC-8G[K6,IPI@H!()+,Z%&.V(#  )R1!_LXRRPJ!!)H,^S+9:CP
MC.! P,\SA$0_S(%!;P$HAP#"<W+<M"L0C+<RC6E@9F*#C_^Z>*% ,+1V.$.8
M:ZW&4VPC"&A7/;Y$S0AH,VI.<FH#P((\3W.WIC5A6'6:]EP&.OD2I855-.(1
M954@./@9YG[# " 3*3*  =%J+L4 $-3GU7L\C9L 0  ?1T"%D5G, 'I+$'9$
M"@!1!H"(4@,:<ZW#6R2"W&K YB(0S 4?&%9 N1?(&7PH=7T :("<NDW<$= #
M!Z1IP&-/?= #,$Y4:5O8[@K$&?PF1Z< 6*QGJCVSEG'P ,__H$)_55Z%"E#R
MQ@)I-/<B97)X9^935.B&^ H4CS!XW 'QH&9H( &!GS:[-F1;-W30IS+A@!9$
M8BY.,7?NHJ*I%*>>BL (6+28S6Y.RU7(F\#,=&QK*2<V/\ O9Q8C,,\@  2S
M)=R !X+M0B>!KIVD>$TC1H5TT%JEWN-<$I(  @E$(*Q:UDQC'E/O@31O5(D1
M0.XN-^BF.>G-@-/AS?.GP *%(0P@('P$)' 7?R ',V8]NKP77C#+Z:X<J_DI
M:/-E'0:@%C.0:,^UMI'(RA"@><&)@"- -#Q;$JQSQ)N3MR['NBH,/@(1 !MH
M1;3=/W1Q.SW;^%5!, (+[%+O@YT'_ZC<5T6=KD;05?S<BZXXD&Y0"V'V$%AJ
MV,HL;O$- ?206>M\5B)<Z<L<[5-_>Q0&.;=SIB%&+[(86G<7Z0!(@81TK <=
MCJ ^OW%\:;%# J%E$_!#NN,("?1XFY)3 M$-D* C\M ^4%1Y ^%GL (KX\%;
M\= Z]X8?XO(C\!8/<!0;5U1\IA$/BF99QR80#? JX#=8JV$!]M -F&%/UT(P
M%2  +T@0+-(W^Y$O20 !\18<(JAF2-(GQ5&%KG(/ C,7$41&-F<SCH&%^G(W
M 7 /-6)\!2,X[(-PL3$"4.@G + K/W /R;$8F18  #("OQ,;2: /E=9+G(,P
MG-(CYH(T$_]$0P2!9%IE)<6C9622*&X%#FF((FFAB427''R"'>[5044840C0
M<NQ  '2U'Q'P X!A#Y-#700! FPD-R,P2W8S6Q: &Q#P X^591,W$+U(='XG
M$,,R6R!P2GL47>UD 4,R&_Q5!<F$ )-#=!Y%2:2Q,4]21A^$A17P *C%,E1D
M /_%;Q-0C;[A'5MW7R.P']VPBB(S.=\ 5ZEQ !7P0?*0=M=8 >TH$ ^@8W@1
M 34B3"$'=[[W7_-%.X3Q6P'F/0(!97C#5*4XD12I$MA6D1NA,1/P ("!#Q/@
M&>DP/_DQ >8P8A-@=!A94Q!&3NZ2DAH1 !;0&QMH#]\P3FUA80+_( %/(@\K
M%@$ZLTODY)(218VA 0*[)906D4\ \&!^9WO/$ #600X3$ %]H0#?8 \6H#0(
M\$%(^5 (DEA=.1& "'T'@ "9QPZAI%-OEWD/4(C">%9?&9=R.9=T69=V>9=X
MF9=ZB9?Y(' (4@Y?20 R)YAU"3'Y4 Y]29AQ"9@"-Y@(<IA_"5-9\Y@P59F4
MF0_=D ^8F9B2*9F)^0R<"3&&"9B*&9>$>9J-!IF'B9F-.9?:D0^"&9H( C$[
M4IN&F35]^9B9Z9>;29>Y^9N R9J%.9NSF9J4*9J!V6*O69S,N9?.^9S0&9W2
M.9W/*9@OX6GTH XQ>3WKT \"T!VLE7G@__5AXB)7$ (! M ;WY2>ZPF( <">
M[^F>\#F?\EF?[7F?\8F?]*F?]IF?_KF?O9&>O<$.Z5F@Z4F@ZAF?[AF?\RF@
M AH !"J@W^2?[VF@"@JA ]H;"UJ@#%J?'"J@]U"A\LFA&=JA'YJ@ I"B'1J@
M[MF>(^J?ZSFA+BI>"6JB&OJ@&)JC[2F@"'JC+\JC**JB'(J>[8F@#JJA,HJB
M_0F@3+JD3LJ?4/J?3RJE4=JD53JE['E9**$9^_!G>#(!$@8A(\"68?*6%H(P
M_>)2:KJF;-JF;OJF<!JG<CJG=)I2=0JG]'"G>KJG"/,.?/JF?KJG@?JGA*JG
M@]JF?GJH;9JGA?_:J([ZJ)#:J&")$@K ;^)B &9"#]] +H3!31&P450RE?S!
M; ?1#UHZ-=T5EJKZ$>DY >,D&! @<8S" !8P ?R@5@T0 :%D+H"XE;D5B26Y
MJL*J=Q,@ $TD )8Z .FI<\_D3 8@ .99$*8ZK-1:K0^Q#N-FK=JZK9%XJMSZ
MK6&Y#M$*KN3:E=-:KN@:KN.:KNQ:BN#@K>T:KZJU#\$JK_:J=P$@:/>ZKRXV
M:?SZKUMU&P [L!"%K01[L QUK@B[L 8EK@S[L*]!,1Z%5XDUJ00!#N0)L1K[
M%7"B)2 0 ;4:."!@ 6[B363I(B K !8+ /2ZL2[K%?^5%I]*$ \@ 03_<  6
M@#/FDJO;0$[ET!L)D:\O.[19L4S3*@$>F6V H0^/AB??]":=@A#@4*]$6[51
MP2-KT1<C\$W^EBK[,0!XQA@_H ["F+$"\1OK4)7:L;8[PK9NV[9P^[9R&[=T
M.[=V6[=X>[=ZF[=\N[=^V[> ^[>"&[B$.[B&6[B(>[B*F[B,N[B.V[B0Z[8N
M<3'[T!<$20^[&*8G(IX_8*G(Q"!)>J$G.KHV2KJF6[JH>[JJF[JLN[JNV[JP
M^[JR&[NT.[NV6[NX>[NZF[N\N[N^V[O ^[LD*J'P.A(*, +0%W;9FH?+I(Q3
MN23CM ]06['?$0 GR0"., #?D;W8J[W<^[W>_QN^W3N^X$N^XEN^Z'N^ZFN^
M[)N^[;N^[AN_\#N_[UN_\FN_]'N_^IN__(N__KN__]N_ #S  ES  7S !(S
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MZ[F.Z[3.Z[K>Z[L>[, ^[+]>[+Y^[,)N[+GNZ9H>0YPNZO@@#SB  ^8@ A1
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M8M^%-UZ#*' -!R7E+:B<\$*0)X_A0/Q(@?Q"!&"[;=[YTK)N"""@' 0>V.:
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MK%EE&R+0 P6XP362<*-940&' 8 'DO\   \$$X@ ;^I' ';,#P 1L$<$Z**
M")A$,2[\R*4".,/_R05$Y7@&&"XB.,_)Y0Q]P=:VJO,R!XP  AOLB (0(X '
M!, @$$"  .I1$)VPPR#@L( ) 2 !)![$ /RC81@Q]HX/X$ >'_@ !<)C$!L.
MZ7]KDXV!%-" "%3! 53K"!U'8( ):'$=ZX  ;@X "2<6Q!Z0<!<4.4(8!@2
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MC+B!?NHF:BL-#=$G75D'?:"V?)K+;<K*L!*-R/PFR.R'K02G;,B#$"BGL((
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M14.JV+%T>X<=4U JF[0P(96S%8$9D6%2_HR*T!:NN0A=IA-\  %(J((9@XD
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M003DYBS8,Q"AW(,("" $R!< @CD)P!G6AN[^/>@)$8 ?L$  @((("B T&!C
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MD X(- U@GP#5D=- !#LI8 %V.#$0 4H+K8-/@^VZ"]FD X$;@'C71B" !/P
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M<X H"T8^3&8/.>91$<@!LB+DL, ZSKP0[!Q$ DG %$0>8($$@0 $T76(WB2
M@P#TF;T,\0? (F"!"=C# HZ B&PA ((DD(,?9,X2!,@Q@B2H1R+R^485[M9#
M^ZZ#' @0 , L4&.'/,!N$2BFG&_\:@M$  1Y;8BG[ 8"":R:(038![G"%H!O
MC/HMEP8  3Q%#L'B8YN02Q\ GF$/,N,C"7+;23JFG1C_ TC@C-?=T'D,T&N'
M('H=USFV?QB '0$T@&P0T1M>1X"/P-YZ3.&"P @.T(UO0>0W^)@= !H@ 3+K
M SEN[4V]266F=!R '?8X#IDC\(!NX-8<_GH( BQP .545 +*U4T$L+2/>2
MO@G!SE_RX9N/R_@XZ=(;BQF"'8LM)\ ,.%Q!'@[IY9%9 0Q'GG8?H@ C)X_!
MO@G /I"^C@F067(*\ ["^_V <C"@QQ$@\D*>42\<@&  [\ Y8A+T#'W\39<!
M;FT^]G$W739=0O@@1P0\5VR&"( FSQB/DN>ND)+CIW3^*%U#XG4 :P+ 'I^U
M+SG"-"IR!+BBFBH=886NGX$\_P A>"-W! P"9L W!#T%DI H]P7XS6Z#\PQY
M84$$$,V!D"DA!TC\0R3PZ() P- *P8?I3PV1"23!3&=$>H#7,8+?6RGA!3F
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M) $Y%:=XHM_^!0 .,L3W 4 W7)3X]8[%-$ Y)1/?><A_**%#0&"7Y"=<:M]
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M('N??TY$7.''&VL*.>T#!-##)GM?Z;0K@+F@<.'$L,XQVC:&>#3 3+PM'4D
M! O=DX4()=?#Y>W'=6T*Q*A#NA8$O<S'&YN(/SP<NJW70&Q@1$!.@BBDIRD:
M\DKN )Q+,!='J5*R@%P'4)I8> ",AN7# ?B#38B*1)B6/:1.@N6B.AS_L$3@
M0-P Z+NER-SD[X7,D8;1"P+ \E="! + S7  F(G@\F-\Z'_(<VQ"@#T\P[GT
MLRR/K L* ,#N'0@FW2 S3CG VT5X7#GVZ Q_WCHDG4M&Q'BDPP=JLS#+KBZQ
M'MDV6#F5$^CV(]ZXYD6PPW4I,P#@ "K#93GU0])%F-[HFWQ@[4<'Z%MY&CO
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MYZZ9F0@=X^0/';UG8H3( 8 R,TH;OND#W :'/X.M.1!;8S' PQ$W0^!# (S
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M*:G43@$'JDCH@+<,&"$"G-Z)X* && O S*2J2L(D!BQ(HC %("@RH7+H<4
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M@"1RO+<*5L/X<=E5'8C@&P<>P/LVSB0<8EFA(ZN0BU0(=&[@5K*IJ*";ZR$
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#(  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP!#  (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @+_Q &B   !!0$! 0$!
M 0           0(#! 4&!P@)"@L!  ,! 0$! 0$! 0$        ! @,$!08'
M" D*"Q   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&A
ML<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X
M^?K_P  1" $S C,# 1$  A$  Q$ _]H # ,!  (1 Q$ /P#]_* "@ H * "@
M H * "@ H * (Y94@BDFE;;%#&\LC<G:D:EW; R>%!/ SZ4 >-VG[0GP@OO@
MY-\?;7QC:R?"6"UOKV7Q<++4EMDMM-UN?PY>RFS:S&I8AUFVFLB!9[F=#(@:
M(AR ;NG_ !?^'>I^-=#^'=AXBAG\8>(_ ,'Q/T71EM;Y9+SP/<WBV$.N)</;
M+:1Q/=LL0MI9TO 3N-N%^:@#TN@#/T_5=,U07?\ 9>H65^-/O9M-OC97,-R+
M/4+=(I)[*Y,+N(;J%)X6E@DVRQB1"RC<,@&A0!PGCKXE>"OAHGA63QKK<6AI
MXU\9Z'\/O#)DM[N?^T_%WB/[3_8VD(+."<PR7OV.XVSW'E6L?EGS9DRN0#NZ
M "@#@['XF>"=0^(FN?"FRUR&;Q]X;\/:;XJUGP^L%VLUEH.KW!M=/OWN&@6S
M=+F<&-8XKAYE/+QJ.: /&?BC^V=^S9\%_&%WX"^)/Q*L?#/BRPL[&_NM(FTG
M7KN6&TU.W6ZLIFFT_2[JWQ/ PD 64LH.'"GB@#W;P-XZ\'_$GPMI/C7P'XAT
MOQ3X5UN%Y]+UO1KJ*[L;I8II+>=%EB8A)[:YBEMKJWD"3VUS%+;SQQRQN@ .
MLH \E\:?'+X7?#WQEX3^'OBGQ1#8>-/&XC?PWX<MK'4M3U.]MY=0BTI+Z2WT
MNSO&L=..H3+:G4;[[-9"5909QY,I0 ]:H * "@ H * "@ H * "@#R?XC_&_
MX7_"74/"^C^._%-OHVL^-+FZMO"^B16FH:IK.LM8B%K^:STK2;6]OWM+$7-O
M]MO?LXM+7SXO/FC\Q<@'I%YJNF:;-I]M?ZA9V4^JW?V#2X+FYA@EU"]\J2X^
MR64<CJ]S<>1#+,880[B**20KM5B #D_"7Q,\$^.=;\<>'/"NN0ZIK/PVUV/P
MSXSLHX+N%M$UN:U%Y'8RO<00Q3NULPE\RU>:+!P7W<4 =Y0!SWBOQ;X8\">'
M]2\5^,O$&D>%?#.CQQ3:KKVO:A:Z5I&G17%S#:0R7M_>20VULDMU<06Z-+(@
M:::.,$LZ@@%/Q!X\\%>$] M/%/B7Q7X?T#PU?SZ5;6.NZMJUE8:5>7&NRQ0Z
M-!:WUS-';3S:K-/#'I\<4C/=O+&L <L,@'6T % !0 4 % !0!A:OXG\.>'[S
M0-.UO7-*TB_\5:J=#\-6>H7UM9W.NZPMC=ZFVEZ3#/)')?WXT^QO;TVMLLDP
MM;6XG*>7$[  I^)?''@[P9/X>MO%?BC0?#4_BS7;3PQX7AUO5+/3)-?\1ZAN
M^Q:'HZ7<T+:AJMYM;[-86HDN9MI\N-L&@"36?&7A/PYK'AKP]KOB31-&USQE
M=WEAX2T?4=2M++4?$E[IUK]NO[71+.>6.?4KBSLS]JN8K2.5X8#YL@5.: -3
M5]6TOP_I.IZ[K>H6>DZ+HFGWNK:MJNH7$5I8:9IFG6TEY?W]]=3LD-K:6=K#
M+<7-Q*Z10PQO)(RJI( &:)K>D>)-'TKQ#X?U.QUG0M<TZSU?1M7TRZAO=-U/
M2]1MX[NQU"PO+=Y(+JSO+:6.>VN(7>*:&1)(V96!(!J4 5KR[M=/M+J_OKB&
MTLK*WGN[R[N)$AM[6UMHFFN+B>5RJ10PQ(\DLCL$1%9F( )H S/#7B;P[XRT
M+3/$_A/6]+\1^'-:MA>:1KFB7UOJ6E:E:,S(MS8WUI)+;7,+.CJ)(9'0LK#.
M0: -R@#F_#/C#PKXRMM2O/"/B+1?$=IH^MZGX;U6XT34K34H=.\0:-*L&KZ+
M>R6<LJ6VIZ;,RQ7UE*4N+:1@LT:$@4 =)0 4 >+>-/VCO@%\.-?N?"GCWXR_
M#3P;XELH;6XNM \2^,] T75K:"]@2YM)IM/O[^"YBCNK>1)H'>(++$ZNA*L#
M0!ZQH^KZ5X@TG3-=T+4;/5M%UG3[/5M(U73KB*[T_4M,U&WCN[&_L;N!G@N;
M2\M9HKBVN(7>*:&1)(V96!(!HT % '-^&?&'A7QE;:E>>$?$6B^([31];U/P
MWJMQHFI6FI0Z=X@T:58-7T6]DLY94MM3TV9EBOK*4I<6TC!9HT) H Z2@ H
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M%?!(M/'_ ,4O%=]X:_9%UOQE;MK/B.UO=7\0W&@^.;R!?"E_<C28UDT#7[B
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MRU.&^TV6YL;F&UU76UNWTC4I9_/%YI5O#:V\,$B23.!MY?@>&:?HWC:'7?\
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MVEO!JK$WT4-J3;11SJD!,2K0!^B- !0 4 % !0 4 % !0 4 % !0 4 % !0
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MH/@_Q'X T?X<^%=/\'^+H'MO$^@6^E6R6&NP2(8VAU2+9_ID?EDH$F+JJD@
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M4K32['X@^$-#\66NB:BNK:1%K5C%=_V;J2QM"+RS:12UO.8F:-GC*ED.&R*
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MH /^%S_#'_H;M/\ ^^+O_P"1J #_ (7/\,?^ANT__OB[_P#D:@ _X7/\,?\
MH;M/_P"^+O\ ^1J #_A<_P ,?^ANT_\ [XN__D:@ _X7/\,?^ANT_P#[XN__
M )&H /\ A<_PQ_Z&[3_^^+O_ .1J #_A<_PQ_P"ANT__ +XN_P#Y&H /^%S_
M  Q_Z&[3_P#OB[_^1J #_A<_PQ_Z&[3_ /OB[_\ D:@ _P"%S_#'_H;M/_[X
MN_\ Y&H /^%S_#'_ *&[3_\ OB[_ /D:@ _X7/\ #'_H;M/_ .^+O_Y&H /^
M%S_#'_H;M/\ ^^+O_P"1J #_ (7/\,?^ANT__OB[_P#D:@ _X7/\,?\ H;M/
M_P"^+O\ ^1J #_A<_P ,?^ANT_\ [XN__D:@ _X7/\,?^ANT_P#[XN__ )&H
M /\ A<_PQ_Z&[3_^^+O_ .1J #_A<_PQ_P"ANT__ +XN_P#Y&H /^%S_  Q_
MZ&[3_P#OB[_^1J #_A<_PQ_Z&[3_ /OB[_\ D:@ _P"%S_#'_H;M/_[XN_\
MY&H /^%S_#'_ *&[3_\ OB[_ /D:@ _X7/\ #'_H;M/_ .^+O_Y&H /^%S_#
M'_H;M/\ ^^+O_P"1J #_ (7/\,?^ANT__OB[_P#D:@ _X7/\,?\ H;M/_P"^
M+O\ ^1J +5C\6OAWJ5[9Z=8^*+&XO;^ZM[*SMT2Z#SW5U*D%O"I:W50TDLB(
MNX@989('- 'HU !0 4 % !0 4 % ')>//!6A?$?P5XJ\ >)X9Y_#OC'0=3\.
M:W!;7$MI<2Z9J]K)9WD<-S RS6\CP2N$EB970D,I!% '-:U\'?!&N^)5\3:C
M974D\E_X6U?4]*^W7 T'6]:\#W<=_P"#-9U;1RYL[G5?#5]!:7>G7PC2<RZ?
MI?VIKA=*TU;4 =I'PC\+:+XKC\5VLVMO)9ZCXFUG1]#N=8O9O#>@ZUXRE>?Q
M-J^D:*TGV2VU#59KG4Y'N&60VIUO7%L1;1ZM?).!M\OU-/XJ?\DP^(__ &(?
MC#'_ (3VHT =Y@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>
ME !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>
ME !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>
ME !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>
ME !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>E !@>
ME !@>E !@>E "T % !0 4 % !0 4 % !0 4 <%\5/^28?$?_ +$/Q?\ ^H]J
M- '>T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MX<_\&EM_\70 ?\+2^'/_ $.OAS_P:6W_ ,70 ?\ "TOAS_T.OAS_ ,&EM_\
M%T '_"TOAS_T.OAS_P &EM_\70 ?\+2^'/\ T.OAS_P:6W_Q= !_PM+X<_\
M0Z^'/_!I;?\ Q= !_P +2^'/_0Z^'/\ P:6W_P 70 ?\+2^'/_0Z^'/_  :6
MW_Q= !_PM+X<_P#0Z^'/_!I;?_%T '_"TOAS_P!#KX<_\&EM_P#%T '_  M+
MX<_]#KX<_P#!I;?_ != !_PM+X<_]#KX<_\ !I;?_%T '_"TOAS_ -#KX<_\
M&EM_\70 ?\+2^'/_ $.OAS_P:6W_ ,70 ?\ "TOAS_T.OAS_ ,&EM_\ %T '
M_"TOAS_T.OAS_P &EM_\70 ?\+2^'/\ T.OAS_P:6W_Q= !_PM+X<_\ 0Z^'
M/_!I;?\ Q= !_P +2^'/_0Z^'/\ P:6W_P 70 ?\+2^'/_0Z^'/_  :6W_Q=
M !_PM+X<_P#0Z^'/_!I;?_%T '_"TOAS_P!#KX<_\&EM_P#%T '_  M+X<_]
M#KX<_P#!I;?_ != !_PM+X<_]#KX<_\ !I;?_%T '_"TOAS_ -#KX<_\&EM_
M\70 ?\+2^'/_ $.OAS_P:6W_ ,70 ?\ "TOAS_T.OAS_ ,&EM_\ %T '_"TO
MAS_T.OAS_P &EM_\70 ?\+2^'/\ T.OAS_P:6W_Q= !_PM+X<_\ 0Z^'/_!I
M;?\ Q= !_P +2^'/_0Z^'/\ P:6W_P 70 ?\+2^'/_0Z^'/_  :6W_Q= !_P
MM+X<_P#0Z^'/_!I;?_%T '_"TOAS_P!#KX<_\&EM_P#%T '_  M+X<_]#KX<
M_P#!I;?_ != !_PM+X<_]#KX<_\ !I;?_%T '_"TOAS_ -#KX<_\&EM_\70
M?\+2^'/_ $.OAS_P:6W_ ,70 ?\ "TOAS_T.OAS_ ,&EM_\ %T '_"TOAS_T
M.OAS_P &EM_\70 ?\+2^'/\ T.OAS_P:6W_Q= !_PM+X<_\ 0Z^'/_!I;?\
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M12@[:V]HHRMM+0]# XR&+H\Z2IU(.4*M%R7-1G&<X-22VYG!RC?=:GSKXO\
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M2W\&@^-O#NK>&-7ETJ>&VU*+3M9LY;&[>QN+BVO((;I89F,,DUK<1K)@O#(
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M]B:-_P! C3/_   M/_C5 !_8FC?] C3/_ "T_P#C5 !_8FC?] C3/_ "T_\
MC5 !_8FC?] C3/\ P M/_C5 !_8FC?\ 0(TS_P  +3_XU0 ?V)HW_0(TS_P
MM/\ XU0 ?V)HW_0(TS_P M/_ (U0 ?V)HW_0(TS_ , +3_XU0 ?V)HW_ $"-
M,_\  "T_^-4 ']B:-_T"-,_\ +3_ .-4 ']B:-_T"-,_\ +3_P"-4 ']B:-_
MT"-,_P# "T_^-4 ']B:-_P! C3/_   M/_C5 !_8FC?] C3/_ "T_P#C5 !_
M8FC?] C3/_ "T_\ C5 !_8FC?] C3/\ P M/_C5 !_8FC?\ 0(TS_P  +3_X
MU0 ?V)HW_0(TS_P M/\ XU0 ?V)HW_0(TS_P M/_ (U0 ?V)HW_0(TS_ , +
M3_XU0 ?V)HW_ $"-,_\  "T_^-4 ']B:-_T"-,_\ +3_ .-4 ']B:-_T"-,_
M\ +3_P"-4 ']B:-_T"-,_P# "T_^-4 ']B:-_P! C3/_   M/_C5 !_8FC?]
M C3/_ "T_P#C5 !_8FC?] C3/_ "T_\ C5 !_8FC?] C3/\ P M/_C5 !_8F
MC?\ 0(TS_P  +3_XU0 ?V)HW_0(TS_P M/\ XU0 ?V)HW_0(TS_P M/_ (U0
M ?V)HW_0(TS_ , +3_XU0 ?V)HW_ $"-,_\  "T_^-4 ']B:-_T"-,_\ +3_
M .-4 ']B:-_T"-,_\ +3_P"-4 ']B:-_T"-,_P# "T_^-4 ']B:-_P! C3/_
M   M/_C5 !_8FC?] C3/_ "T_P#C5 !_8FC?] C3/_ "T_\ C5 !_8FC?] C
M3/\ P M/_C5 !_8FC?\ 0(TS_P  +3_XU0 ?V)HW_0(TS_P M/\ XU0!P/Q*
M\7?#OX3^%+SQ;XNM]*L;"!OLME"NF12W.JZM+;W$]CH]C#!:RN]Y??9I5C)5
M88D22XN9(;>&65.S X'$8_$1PV%AS3?O2=U&-*FG%3J3;:2C'F5^K;2BG)I/
MFQ>+HX&C*M7ERPCI%6=YS:;C"*2^*5G;HM6VDFSY$7X/:Y^U3K&E?$'Q]X37
MX7^#-"GTRU\+>$+B _V[KNEIJ^G7OBJYUG[-)8/IO]IQZ?=:1IDC6\%S'!<_
M;#!+%!:W%Y],LPP_#5*I@L!66,Q-:,Y8C$PM&C1J.G4CAXT])*I[-U%5FN9Q
M;7+=.4E'P7@JV<U*>*Q=)X2A2<%0H2NZDX>TA*NYV<>3G4'"#LG9\UFDG+W?
MXR?"Z:T^%VEZ#\'_  _I&C:UH7B7P?\ V!'8Z/9R+813:S;Z1>ZC-&T?^D+I
MUGJMWK5_<732%Q:7%W=M,WFE_(RW&PEF%2MF=2=:E6P^*59SG)<]J;JQIIWT
M52=.-*,8V7O1C%+2WI8["2A@X4LOIQHU*5:@Z2A!)0O-4Y3:_N1J2J2D]=&W
M?4^<M7_8\U#1/B3X2>T\4>+O%GA3QWJ3:?\ $H2L]F5TRST;4-6U2?5-0L9$
M^SV6N:O%#;:?:0QPI:F?["9KGSD->U2XAH5,!B(O!X/#8C!P]I@.6$7:I.K"
MG35.$HZSI4VY3FVW+EY[1L>7/):U/%T>7$XFM1Q,N3%WE*/N1ISG-SE%JT:D
M[*,4DE?EN[GWCX:^'O@KP=HMAX>\.^&=(T[2=-25+2V6TBF:/[1,]S.S3W"R
MW$CSSR/+(\DK%F;'"JJK\EB,5B,55G6Q%652I/EYFW;X5:*Y5:*45HDEI=]W
M?Z.AAZ.%IQI4*<:<*=^6*5K<SO)W>MY/5ZZZ=D?&'Q@_8]U+Q3\2=4\5_#G4
M[7P5I?B/0+9-:CLKB=/,\67WBJWM/$&K7.FDI!):R^"=7UN_M8;2>!_[>TV-
M$^RF_$]?3Y;Q%0P^ I87'4?K<\-6E['GA"T<-##N5&E"=FXR6*I482<HM>QG
MKS<ECP<;DM6IBZE?!U?JL*U->U4)R5Z\JR56I*-TFGAZE644FG[6/3GN?67P
MU^$?@WX7>#]-\&:%8_;;#37O9A>:Q%9WFI7-QJ%Y/?7$EQ<):0*X$LYB@41@
MQVT<,3-(R-(_SF/QU;,,5/%5U",YJ$>6FG&$8TX*$5%-MK17>NLFWI>Q[6#P
ME+ T(8>BY<D')WFTY.4Y.4FVDEN[+39):[EN^^%G@V_\;:!X]FTU8];\.Z1J
M^B6<,,=I'ID]GK+P/.;VR-JWG3P-!FTE26$Q^=,)!*#'Y<PQE:EA*V!CR^PK
MU:5:=T^93I*2CRM-))\WO)IWLK6UO4L-2>)I8I\T:M&G4IQL[1Y:EF^96W5M
M&FMW>YV']B:-_P! C3/_   M/_C5<IT!_8FB_P#0(TO_ ,%]I_\ &J  :'HH
M  TC2P!P -/M  !T 'DT?F ?V)HW_0(TS_P M/\ XU0!X1X%_9M\%?#_ .*7
MC'XBZ+#;I:^*-'33XO#TEIY]OIUW=:I_:NM7T<]S-."M_<P60M[:*&&.SCBD
MC4NKJ$]G&9UB,;EV%P%97^K5>?VMTG*,:?LJ,>515G",IWDVW+F3TUOYF%RN
MC@\;7Q='W57I\GLTG:#E/VE25VW\<E&R22C8\_\ @I\4/A3X8^&G@;PMX_\
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MC1KSP]3$X/&SC13<7/"J:JQMI'VDH0A*S:YG&&\K'Z65\.?5A0 4 % !0 4
M% !0 4 % '!?%3_DF'Q'_P"Q#\7_ /J/:C0!WM !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % 'S9^T/\5['PGHES\.M+N[BW^(GQ"TJVT7PC%!OA=&\3
M^(=+\&27]K=QRQO%J6F#6YM4L47!>6P+;U5&->YDN73Q%6.-J1B\%@JDJN);
MLU^XHU,4H2BTTX5/9*G-]%/9W/)S3&QH4WA(2<<5B8*G02TM[:K"@Y)IJTX>
MT<X]W$Q?A3^R_P"'_ OC'Q#XK\1./&-W;ZI;CX>WNN7%WJ5[X:T"VLXX;>T=
M+J5[1[ZS=-EKJ"P?:XH@Y297GF+ZYAG];%X:AAJ"^JP=.7UR%)1IPKUI2;E)
M<J4E":=Y0ORMVTT5L\%D]+"UZM:K^_E&:^JRJ.4I4::BDH^\^7FC]F5N9*^N
MK/JT#' X Z <8_PKYX]K;RM\K7"@ H * "@ H * "@ H * "@ H _-WX<_LJ
M:=XJ^)WQP'Q;\*7[>&-*U^[MOA9NU"ZMK1=!\0^)O&?B"2>QFLKJ.:9K1+^S
MF,=V76.?4)A(CN,K]QC>(9X7 93_ &;B(*O4HQEF%H1<O;4:&%HVFI1M'F<)
MJ\;74%9I;_*87)85<9F"QM"7L:=62P7ON,53JUL15;BXM-VYXNTMG)WU/M/X
M,_#>T^$OPT\*^ [67[1+H]ANU.[W,5O-;OY9+_6KJ+?\R6\VI7-R;6)B3#:^
M3$68IN/RV9XZ688[$8MKE52=J<-N2E!*%*+MIS*$8\SZRN^I[^ PD<#A*.&B
M]:<???>I-N522[)S;Y5TC9'I^/;IT]L]:X-O+\#LV\K?*UPH * "@ H \\\?
M_%GX;?"NTAO/B#XST+PG#<?\>JZK>)%<7.7$0^S6B"2ZGW2,$!BA92^1GY6P
M <7X*_::^!'Q!U:'0?"?Q+\.:AKERR);:/)/+8:A<-*YCB6VM[Z&V:X:9P5C
M2$N[G@+F@#W>@#Q#]HOXGZ]\&O@YXZ^(_AOPROBG4_"OA_5M92PGN?LEA;PZ
M7IEYJ,]_J4P_>"RMX[0AHH,3W$TD,$1#2!@ 8?Q!^)_Q#\&^-?"]I9^&-)O?
M".N^+? '@^TA$]S)XIUZX\67DT7B;6-(MX3]GMM*\!Z68M<U:2[4^=96>HA'
M5Q & #PS\5_%>K>)O"D]W8Z$O@;QYX\^)?P^\/\ V7[:NOV.I> 5\936M]J+
M2,;.6UUBU^'GB:=HX462W-SI:9R)]P&QVOQG\1:+HOP[\96&IZA#97>M^"_&
M%II,$@DWWER-#N(3%$41E5O-N[9/G*#,R\XR0 :?_"U_AW_T-6G_ /?%W_\
M(U !_P +7^'?_0U:?_WQ=_\ R-0 ?\+7^'?_ $-6G_\ ?%W_ /(U !_PM?X=
M_P#0U:?_ -\7?_R-0 ?\+7^'?_0U:?\ ]\7?_P C4 '_  M?X=_]#5I__?%W
M_P#(U !_PM?X=_\ 0U:?_P!\7?\ \C4 '_"U_AW_ -#5I_\ WQ=__(U !_PM
M?X=_]#5I_P#WQ=__ "-0 ?\ "U_AW_T-6G_]\7?_ ,C4 '_"U_AW_P!#5I__
M 'Q=_P#R-0 ?\+7^'?\ T-6G_P#?%W_\C4 '_"U_AW_T-6G_ /?%W_\ (U !
M_P +7^'?_0U:?_WQ=_\ R-0 ?\+7^'?_ $-6G_\ ?%W_ /(U !_PM?X=_P#0
MU:?_ -\7?_R-0 ?\+7^'?_0U:?\ ]\7?_P C4 '_  M?X=_]#5I__?%W_P#(
MU !_PM?X=_\ 0U:?_P!\7?\ \C4 '_"U_AW_ -#5I_\ WQ=__(U !_PM?X=_
M]#5I_P#WQ=__ "-0 ?\ "U_AW_T-6G_]\7?_ ,C4 '_"U_AW_P!#5I__ 'Q=
M_P#R-0 ?\+7^'?\ T-6G_P#?%W_\C4 '_"U_AW_T-6G_ /?%W_\ (U !_P +
M7^'?_0U:?_WQ=_\ R-0 ?\+7^'?_ $-6G_\ ?%W_ /(U !_PM?X=_P#0U:?_
M -\7?_R-0 ?\+7^'?_0U:?\ ]\7?_P C4 '_  M?X=_]#5I__?%W_P#(U $<
MWQ=^&UO%)-/XNTN""%&DEEE^TQQQ1J-S.[M;A451R68@ <DTXQ;:C%-MM*,4
MKMMZ))+JQ-J*;;45%-MO1175OL>?7/[5'P/AT236+/QI9:G,(PUOH6G1SSZ]
M>2M,($M[335C\R6>1CO5%/,>7S@5ZZR',XUO93PTJ*5W*K-J-&$8Q<G*5391
M2W\]#SO[6P'L^>%=3>BC3@FZLI-\JC&&]V_PU()OVK?@M!%H\H\2O,FJ:?%J
M5U]EL;J?^P;:2*5F_M_RX_\ B6O#-#+:W"R_ZJX1U8X5B"&0YBY5HQI*+HUG
M02E-1]K42C+EHWM[2\)*HK;Q::W%+-L%!4G[1VG3572+?LH-N-ZMO@]].#OM
M(])C^+?PXEC26+Q9IKQR(LD;JMT5=' 9&4BWP592""."#FO(E%Q;C).,HMQ:
M>C33LT_-/0])--)IW32::V:>J:^0_P#X6O\ #O\ Z&K3_P#OB[_^1J0P_P"%
MK_#O_H:M/_[XN_\ Y&H /^%K_#O_ *&K3_\ OB[_ /D:@ _X6O\ #O\ Z&K3
M_P#OB[_^1J #_A:_P[_Z&K3_ /OB[_\ D:@ _P"%K_#O_H:M/_[XN_\ Y&H
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MM/\ ^^+O_P"1J #_ (6O\._^AJT__OB[_P#D:@ _X6O\._\ H:M/_P"^+O\
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MKIV:T\[IEK^SM/\ ^?"S_P# 6#_XBI&']G:?_P ^%G_X"P?_ !% !_9VG_\
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M"EW>0WEU+;>(K1=0GTKQ1X>UN,RRVG]L:-JTD$L%K# =/$\)N5 .1^''@O\
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MM;PQSN'VZ7XA\&W%S++$"DLJPP2,JS%GC(RP>4X3 SE&-2>/QN+JTEO'V#6
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M7XA^![VYM[*T\4Z+<75W/#:VMO%>Q-+/<3R+%##&H.6DED=411R68 4 =E0
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M"Z3_ ."VS_\ C- !_8&A?] 72?\ P6V?_P 9H /[ T+_ * ND_\ @ML__C-
M!_8&A?\ 0%TG_P %MG_\9H /[ T+_H"Z3_X+;/\ ^,T ']@:%_T!=)_\%MG_
M /&: #^P-"_Z ND_^"VS_P#C- !_8&A?] 72?_!;9_\ QF@ _L#0O^@+I/\
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MRY(\VZ>]NZ3.IKG-@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#
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M ,'^E?\ R70 ?\)MX,_Z&[PQ_P"#_2O_ )+H /\ A-O!G_0W>&/_  ?Z5_\
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M $K_ .2Z #_A-O!G_0W>&/\ P?Z5_P#)= !_PFW@S_H;O#'_ (/]*_\ DN@
M_P"$V\&?]#=X8_\ !_I7_P ET '_  FW@S_H;O#'_@_TK_Y+H /^$V\&?]#=
MX8_\'^E?_)= !_PFW@S_ *&[PQ_X/]*_^2Z #_A-O!G_ $-WAC_P?Z5_\ET
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MVU_^-T '_"$>#_\ H6=$_P#!;:__ !N@ _X0CP?_ -"SHG_@MM?_ (W0 ?\
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M ?\ "$>#_P#H6=$_\%MK_P#&Z #_ (0CP?\ ]"SHG_@MM?\ XW0 ?\(1X/\
M^A9T3_P6VO\ \;H /^$(\'_]"SHG_@MM?_C= !_PA'@__H6=$_\ !;:__&Z
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M&"6YE$03=F@#]"J "@ H * ."^*G_),/B/\ ]B'XO_\ 4>U&@#O: "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * /C_]JCP)XJ\9Z=IEI_PF_P )/#O@^YUGP7I>EZ7\
M4/!4OBJ"X\=:IJNN:);?8E&K6$<M]K(U[1-+TJVCC:>&2'47+/'= 0@'C_[#
MUMX6B\8?%"+P]\1?@7XSO-"M[;0=9L/A3\.[OP/JFFW5OJ]Y"US?W%WJ%V-8
MT:6YL+VUM;BS1[,WEM+LN792M 'Z04 % 'RMXM^/UWHGQ3U#PC;?V/9:)X3\
M4_#WPKXCEUBSUQ(KVY^(EK87-M,GB:SLI]"\-75LNL:5:^&M,UAFD\;ZY)=Z
M';SZ1+#:W%Z 5OA+\?/$'C;6OA"VL:=ID?A[X_?#+Q9\4?!"622P:CX7L?#-
MYX/DM]"UR1[BXAUFYU;0?&^G:@^H6L>G1Z??Z?>Z>+6\BEAO0!L>Q?&+6M'T
MKX<>-[/4M5T[3[K5?!/C"VTNVO+VWM9]0N/["NHC!8PS2))=3>9<V\?EP*[[
MYX5QF1 0#<_X6-\/O^AW\)_^%#I7_P E4 '_  L;X??]#OX3_P#"ATK_ .2J
M #_A8WP^_P"AW\)_^%#I7_R50 ?\+&^'W_0[^$__  H=*_\ DJ@ _P"%C?#[
M_H=_"?\ X4.E?_)5 !_PL;X??]#OX3_\*'2O_DJ@ _X6-\/O^AW\)_\ A0Z5
M_P#)5 !_PL;X??\ 0[^$_P#PH=*_^2J #_A8WP^_Z'?PG_X4.E?_ "50 ?\
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MATK_ .2J #_A8WP^_P"AW\)_^%#I7_R50 ?\+&^'W_0[^$__  H=*_\ DJ@
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M .%#I7_R50 ?\+&^'W_0[^$__"ATK_Y*H /^%C?#[_H=_"?_ (4.E?\ R50
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M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
M_D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_
M -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__
M .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/
M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
M_D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_
M -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__
M .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/
M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
M_D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_
M -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__
M .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/
M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
M_D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_
M -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__
M .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/
M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
M_D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_
M -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__
M .1Z #_A%_#/_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/
M_0NZ%_X*-/\ _D>@ _X1?PS_ -"[H7_@HT__ .1Z #_A%_#/_0NZ%_X*-/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * /SV_:)\=ZC\/_ -K+]G_7OB'XFUWPC\ =/\&^,+JV
MU+3//70+WXNR7!T^WT[QO-"CK;Z4/"UZT^E&YVPS:B)54[E9D V\B3]F'QSJ
M7C[]I?\ :;U_P5XA\0^*/@)?V?@2[T'5=3^T-H*?$9K2XM_%-EX0GN(HQ)I\
M-G;V@O8[<M#;RBT'63S) -OE\MS]!: "@#R#QC\5K;PS\1?AM\/;.S34;SQC
MJFK1^(+A9MH\+Z-9^"_&'B33KVX10=UUK>H>%Y;'3[9]GG6MMJ]TI/V+# 'G
M?PL_:"U'QWK?POAU'P_8:;H'QN^'?BGXE_#F\LKRYFOXM%\-7WA7_0O$EM/!
M%%;:CJ&B^,]'U* 6,EQ!&\-_;RR*Z1;P#USXN7UE9_#7Q]#<W=O;S7?@;QA%
M:132I%)<2?V!>IY<"LP,C[I8UVH"<R(,989 .K_X2;P[_P!!S2O_  .MO_CE
M !_PDWAW_H.:5_X'6W_QR@ _X2;P[_T'-*_\#K;_ ..4 '_"3>'?^@YI7_@=
M;?\ QR@ _P"$F\._]!S2O_ ZV_\ CE !_P )-X=_Z#FE?^!UM_\ '* #_A)O
M#O\ T'-*_P# ZV_^.4 '_"3>'?\ H.:5_P"!UM_\<H /^$F\._\ 0<TK_P #
MK;_XY0 ?\)-X=_Z#FE?^!UM_\<H /^$F\._]!S2O_ ZV_P#CE !_PDWAW_H.
M:5_X'6W_ ,<H /\ A)O#O_0<TK_P.MO_ (Y0 ?\ "3>'?^@YI7_@=;?_ !R@
M _X2;P[_ -!S2O\ P.MO_CE !_PDWAW_ *#FE?\ @=;?_'* #_A)O#O_ $'-
M*_\  ZV_^.4 '_"3>'?^@YI7_@=;?_'* #_A)O#O_0<TK_P.MO\ XY0 ?\)-
MX=_Z#FE?^!UM_P#'* #_ (2;P[_T'-*_\#K;_P".4 '_  DWAW_H.:5_X'6W
M_P <H /^$F\._P#0<TK_ ,#K;_XY0 ?\)-X=_P"@YI7_ ('6W_QR@ _X2;P[
M_P!!S2O_  .MO_CE !_PDWAW_H.:5_X'6W_QR@ _X2;P[_T'-*_\#K;_ ..4
M '_"3>'?^@YI7_@=;?\ QR@ _P"$F\._]!S2O_ ZV_\ CE !_P )-X=_Z#FE
M?^!UM_\ '* #_A)O#O\ T'-*_P# ZV_^.4 '_"3>'?\ H.:5_P"!UM_\<H /
M^$F\._\ 0<TK_P #K;_XY0 ?\)-X=_Z#FE?^!UM_\<H /^$F\._]!S2O_ ZV
M_P#CE !_PDWAW_H.:5_X'6W_ ,<H /\ A)O#O_0<TK_P.MO_ (Y0 ?\ "3>'
M?^@YI7_@=;?_ !R@ _X2;P[_ -!S2O\ P.MO_CE !_PDWAW_ *#FE?\ @=;?
M_'* #_A)O#O_ $'-*_\  ZV_^.4 '_"3>'?^@YI7_@=;?_'* #_A)O#O_0<T
MK_P.MO\ XY0 ?\)-X=_Z#FE?^!UM_P#'* #_ (2;P[_T'-*_\#K;_P".4 '_
M  DWAW_H.:5_X'6W_P <H /^$F\._P#0<TK_ ,#K;_XY0 ?\)-X=_P"@YI7_
M ('6W_QR@ _X2;P[_P!!S2O_  .MO_CE !_PDWAW_H.:5_X'6W_QR@ _X2;P
M[_T'-*_\#K;_ ..4 '_"3>'?^@YI7_@=;?\ QR@ _P"$F\._]!S2O_ ZV_\
MCE !_P )-X=_Z#FE?^!UM_\ '* #_A)O#O\ T'-*_P# ZV_^.4 '_"3>'?\
MH.:5_P"!UM_\<H /^$F\._\ 0<TK_P #K;_XY0 ?\)-X=_Z#FE?^!UM_\<H
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M<?#[_H1_"?\ X3VE?_(M !_PKCX??]"/X3_\)[2O_D6@ _X5Q\/O^A'\)_\
MA/:5_P#(M !_PKCX??\ 0C^$_P#PGM*_^1: #_A7'P^_Z$?PG_X3VE?_ "+0
M ?\ "N/A]_T(_A/_ ,)[2O\ Y%H /^%<?#[_ *$?PG_X3VE?_(M !_PKCX??
M]"/X3_\ ">TK_P"1: #_ (5Q\/O^A'\)_P#A/:5_\BT '_"N/A]_T(_A/_PG
MM*_^1: #_A7'P^_Z$?PG_P"$]I7_ ,BT '_"N/A]_P!"/X3_ /">TK_Y%H /
M^%<?#[_H1_"?_A/:5_\ (M !_P *X^'W_0C^$_\ PGM*_P#D6@ _X5Q\/O\
MH1_"?_A/:5_\BT '_"N/A]_T(_A/_P )[2O_ )%H /\ A7'P^_Z$?PG_ .$]
MI7_R+0 ?\*X^'W_0C^$__">TK_Y%H /^%<?#[_H1_"?_ (3VE?\ R+0 ?\*X
M^'W_ $(_A/\ \)[2O_D6@ _X5Q\/O^A'\)_^$]I7_P BT '_  KCX??]"/X3
M_P#">TK_ .1: #_A7'P^_P"A'\)_^$]I7_R+0 ?\*X^'W_0C^$__  GM*_\
MD6@ _P"%<?#[_H1_"?\ X3VE?_(M !_PKCX??]"/X3_\)[2O_D6@ _X5Q\/O
M^A'\)_\ A/:5_P#(M !_PKCX??\ 0C^$_P#PGM*_^1: #_A7'P^_Z$?PG_X3
MVE?_ "+0 ?\ "N/A]_T(_A/_ ,)[2O\ Y%H /^%<?#[_ *$?PG_X3VE?_(M
M!_PKCX??]"/X3_\ ">TK_P"1: #_ (5Q\/O^A'\)_P#A/:5_\BT '_"N/A]_
MT(_A/_PGM*_^1: #_A7'P^_Z$?PG_P"$]I7_ ,BT '_"N/A]_P!"/X3_ /">
MTK_Y%H /^%<?#[_H1_"?_A/:5_\ (M !_P *X^'W_0C^$_\ PGM*_P#D6@ _
MX5Q\/O\ H1_"?_A/:5_\BT '_"N/A]_T(_A/_P )[2O_ )%H /\ A7'P^_Z$
M?PG_ .$]I7_R+0 ?\*X^'W_0C^$__">TK_Y%H /^%<?#[_H1_"?_ (3VE?\
MR+0 ?\*X^'W_ $(_A/\ \)[2O_D6@ _X5Q\/O^A'\)_^$]I7_P BT '_  KC
MX??]"/X3_P#">TK_ .1: #_A7'P^_P"A'\)_^$]I7_R+0 ?\*X^'W_0C^$__
M  GM*_\ D6@ _P"%<?#[_H1_"?\ X3VE?_(M !_PKCX??]"/X3_\)[2O_D6@
M _X5Q\/O^A'\)_\ A/:5_P#(M !_PKCX??\ 0C^$_P#PGM*_^1: )[;P#X&L
MKBWO+3P=X8M;NTFBN;6YM]"TR&>WN('66&>"6.V5XIH9%62.1&5T=592" :
M.MH * "@ H * "@ H * "@ H X+XJ?\ ),/B/_V(?B__ -1[4: .]H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MB>.&6\F_L&[C,5LCL&EDWW$*;4!.Z6,8RPR =!_PGG@O_H:-#_\ !E;?_'*
M#_A//!?_ $-&A_\ @RMO_CE !_PGG@O_ *&C0_\ P96W_P <H /^$\\%_P#0
MT:'_ .#*V_\ CE !_P )YX+_ .AHT/\ \&5M_P#'* #_ (3SP7_T-&A_^#*V
M_P#CE !_PGG@O_H:-#_\&5M_\<H /^$\\%_]#1H?_@RMO_CE !_PGG@O_H:-
M#_\ !E;?_'* #_A//!?_ $-&A_\ @RMO_CE !_PGG@O_ *&C0_\ P96W_P <
MH /^$\\%_P#0T:'_ .#*V_\ CE !_P )YX+_ .AHT/\ \&5M_P#'* #_ (3S
MP7_T-&A_^#*V_P#CE !_PGG@O_H:-#_\&5M_\<H /^$\\%_]#1H?_@RMO_CE
M !_PGG@O_H:-#_\ !E;?_'* #_A//!?_ $-&A_\ @RMO_CE !_PGG@O_ *&C
M0_\ P96W_P <H /^$\\%_P#0T:'_ .#*V_\ CE !_P )YX+_ .AHT/\ \&5M
M_P#'* #_ (3SP7_T-&A_^#*V_P#CE !_PGG@O_H:-#_\&5M_\<H /^$\\%_]
M#1H?_@RMO_CE !_PGG@O_H:-#_\ !E;?_'* #_A//!?_ $-&A_\ @RMO_CE
M!_PGG@O_ *&C0_\ P96W_P <H /^$\\%_P#0T:'_ .#*V_\ CE !_P )YX+_
M .AHT/\ \&5M_P#'* #_ (3SP7_T-&A_^#*V_P#CE !_PGG@O_H:-#_\&5M_
M\<H /^$\\%_]#1H?_@RMO_CE !_PGG@O_H:-#_\ !E;?_'* #_A//!?_ $-&
MA_\ @RMO_CE !_PGG@O_ *&C0_\ P96W_P <H /^$\\%_P#0T:'_ .#*V_\
MCE !_P )YX+_ .AHT/\ \&5M_P#'* #_ (3SP7_T-&A_^#*V_P#CE !_PGG@
MO_H:-#_\&5M_\<H /^$\\%_]#1H?_@RMO_CE !_PGG@O_H:-#_\ !E;?_'*
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M_0K^'O\ P2Z=_P#(U !_PAWA'_H5_#W_ ()=._\ D:@ _P"$.\(_]"OX>_\
M!+IW_P C4 '_  AWA'_H5_#W_@ET[_Y&H /^$.\(_P#0K^'O_!+IW_R-0 ?\
M(=X1_P"A7\/?^"73O_D:@ _X0[PC_P!"OX>_\$NG?_(U !_PAWA'_H5_#W_@
MET[_ .1J #_A#O"/_0K^'O\ P2Z=_P#(U !_PAWA'_H5_#W_ ()=._\ D:@
M_P"$.\(_]"OX>_\ !+IW_P C4 '_  AWA'_H5_#W_@ET[_Y&H /^$.\(_P#0
MK^'O_!+IW_R-0 ?\(=X1_P"A7\/?^"73O_D:@ _X0[PC_P!"OX>_\$NG?_(U
M !_PAWA'_H5_#W_@ET[_ .1J #_A#O"/_0K^'O\ P2Z=_P#(U !_PAWA'_H5
M_#W_ ()=._\ D:@ _P"$.\(_]"OX>_\ !+IW_P C4 '_  AWA'_H5_#W_@ET
M[_Y&H /^$.\(_P#0K^'O_!+IW_R-0 ?\(=X1_P"A7\/?^"73O_D:@ _X0[PC
M_P!"OX>_\$NG?_(U !_PAWA'_H5_#W_@ET[_ .1J #_A#O"/_0K^'O\ P2Z=
M_P#(U !_PAWA'_H5_#W_ ()=._\ D:@ _P"$.\(_]"OX>_\ !+IW_P C4 '_
M  AWA'_H5_#W_@ET[_Y&H /^$.\(_P#0K^'O_!+IW_R-0 ?\(=X1_P"A7\/?
M^"73O_D:@ _X0[PC_P!"OX>_\$NG?_(U !_PAWA'_H5_#W_@ET[_ .1J #_A
M#O"/_0K^'O\ P2Z=_P#(U !_PAWA'_H5_#W_ ()=._\ D:@ _P"$.\(_]"OX
M>_\ !+IW_P C4 '_  AWA'_H5_#W_@ET[_Y&H /^$.\(_P#0K^'O_!+IW_R-
M0 ?\(=X1_P"A7\/?^"73O_D:@ _X0[PC_P!"OX>_\$NG?_(U $L/A3PO;317
M%OX<T*">"1)H)X=)L(I89HF#QRQ2);J\<D;JKHZ$,C ,I! - &_0 4 % !0
M4 % !0 4 % !0!P7Q4_Y)A\1_P#L0_%__J/:C0!WM !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ?/OASXN:_J_B?PT+G1M(B\#^.?&OQ%\ ^&+VVNK
MDZ[:ZU\/AXJ<W.JQN6L[BQU^W\!^+;NV6T2WETY(M+BF:\:YF>$#;R.[^+=]
M96?PT\?PW5Y:VLUWX&\816D5Q<0P27,G]@7J>7;QR.K3/NEC79$&;=(@QEU!
M .K_ .$F\-_]#!HG_@VL/_DB@ _X2;PW_P!#!HG_ (-K#_Y(H /^$F\-_P#0
MP:)_X-K#_P"2* #_ (2;PW_T,&B?^#:P_P#DB@ _X2;PW_T,&B?^#:P_^2*
M#_A)O#?_ $,&B?\ @VL/_DB@ _X2;PW_ -#!HG_@VL/_ )(H /\ A)O#?_0P
M:)_X-K#_ .2* #_A)O#?_0P:)_X-K#_Y(H /^$F\-_\ 0P:)_P"#:P_^2* #
M_A)O#?\ T,&B?^#:P_\ DB@ _P"$F\-_]#!HG_@VL/\ Y(H /^$F\-_]#!HG
M_@VL/_DB@ _X2;PW_P!#!HG_ (-K#_Y(H /^$F\-_P#0P:)_X-K#_P"2* #_
M (2;PW_T,&B?^#:P_P#DB@ _X2;PW_T,&B?^#:P_^2* #_A)O#?_ $,&B?\
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M_P"#:P_^2* #_A)O#?\ T,&B?^#:P_\ DB@ _P"$F\-_]#!HG_@VL/\ Y(H
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MS4+=9#+;VNJVS1I()$0R6TZNF5=20#JO^%<>!?\ H5M'_P# 5?\ &@!#\.?
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M7\"?"]K:YL]/B\->(9?[4UW47DMYK*\EMXM4US4-2CLR+6:0I!IB7L>F6^X
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M%73O%%S+XFNX;#3]9N;CP;XV\(V.APW<\T"07UQ=>*8[RT82"0O8%8OWK(0
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M@S^(5CTZ9Y'@BM-=DU&RB99)8;B*W2X@ED@EC=@#Z-H * "@ H * "@ H *
M"@ H * //?'GASX>W8TCQCXYM/#T3^!;FYU/2=?UV6RL8=*?4+.XTBXMKC4;
MQH8ETW4DOEAN-/N9397=VMA.\+WEG920@?UV.9^ 7CG2/B'\,O"?BJUM/">D
M>(=7\.Z#J7C/PYX3O=,O(?#7B+4--ANKS1KTZ=+*\4]G*\L*)>$7!2,D@\T
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MG!X\O=!L?"NI6[Z5JC>)+^STW29X=01H#:3W5]/;P*]R&9(E$J2E\&$B100
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M3V,U_I\>@W[WME%>VK)<V<EU;B2!+JV99X&<2PD2*M 'SI\(_&6F:)\4M/\
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M%)8]: V\K?*URY>6%CJ$0@O[*TO8%<2K#>6T-S$LBAE601S(Z!PKNH<#< S
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M.B^&FDV.J&YU6&W\4I-%8W6IVGAZ0K]IN]%TW5,:=J5['@J;.X^9D;S(09$
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MC7%[>W3R7%S,41%,DLC,551G % 'U/0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?_:7!H ;=:%HM[<VEY>Z3IUU=V  L;FXLK>6>T .X"VDDC9X0#R!&5 /(YH
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M#HVF0QPV-SID21V-LBQ:=>.9+JQC58P$M+ER7GMUQ%*Q)=230&WE;\+CM/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
0* "@ H * "@ H * "@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
